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SUMMARY
The genome of herpes simplex virus type 1 (HSV-1) contains seven genes whose 
products are directly involved in viral DNA replication. These are UL5, UL8, UL9, UL29, 
UL30, UL42 and UL52. I investigated the products of genes UL5, UL8, UL9, and UL52, 
as these were the least characterised. Peptides were synthesised with sequences 
corresponding to portions of the amino acid sequence of these proteins and the peptides 
were used to generate antisera in rabbits. The peptides produced sera reacting with two of 
the four proteins — UL8 and UL9. Sera were produced that reacted with both the N and C 
termini of UL8.
The project now focused on UL8 protein which was purified to homogeneity to 
allow its further characterisation. An existing recombinant baculovirus/Spodoptera 
frugiperda expression system was used as a source of the protein. The protein was 
extracted from the cells in a soluble form and was stable in the extraction buffer (neither 
denatured nor proteolysed) for at least 4 hours at room temperature. The protein was also 
stable during freezing and thawing, dilution, and incubation at 4 °C. A rapid and simple 
purification scheme was developed using DEAE sepharose and phenyl sepharose columns. 
Ten per cent glycerol was required in all buffers for successful chromatography. The 
purification produced UL8 more than 95% pure in only 3 V2 hours beginning with the 
crude extract. The pure protein was intact and free from degradation products as 
determined by reaction with the N and C termini-specific sera.
Gel filtration chromatography established that the molecular mass of the purified 
protein was 75* +/-10 kD, indicating that it is a monomer in solution. (The protein’s 
predicted molecular mass is 80 kD.)
The possible interaction of UL8 with nucleic acids was investigated using a gel 
band shift assay. Despite extensive investigation of different conditions this revealed no 
interaction of UL8 with fully or partially duplex DNA, single stranded DNA, or with a 
DNA/RNA hybrid.
An ELISA assay was established using purified UL8 as antigen. Optimum 
conditions were found for detecting antibodies to UL8 so that the assay could be used to 
screen hybridoma cell lines for UL8-specific antibody production. A cell fusion was 
performed using sple nocytes from a mouse immunised with purified UL8 and this 
produced eighty one hybridoma lines of which 25 produced antibodies specific for UL8 in 
the ELISA assay. From these, nineteen ascites fluids were produced which contained 
antibodies specific for UL8 protein (again measured in ELISA assays). Six of these ascitic 
fluids reacted with UL8 in Western blotting experiments and seven immune precipitated 
UL8 from solution. Rabbit polyclonal sera specific for the protein were also produced.
Possible future work is discussed as well as the implications of these experiments 
for studies of HSV-1 DNA replication.
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It was a slow day
And the sun was beating on the soldiers by the side o f the road
There was a bright light
A shattering o f shop windows
The bomb in the baby carriage was wired to the radio
These are the days o f miracle and wonder
This is the long distance call
The way the camera follows us in slo-mo
The way we look to us all
The way we look to a distant constellation
That's dying in a comer o f the sky
Medicine is magical and magical is art
The Boy in the Bubble
And the baby with the baboon heart
These are the days o f miracle and wonder 
And don't cry baby, don’t cry 
Don't cry
Paul Simon
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INTRODUCTION
The work presented in this thesis concerns DNA replication in herpes simplex 
virus type 1 (HSV-1). The introduction will describe relevant aspects of HSV-1 biology 
with emphasis on DNA replication. DNA replication in some other systems will also be 
discussed.
I) TAXONOMY OF THE HERPESVIRIDAE AND MEDICAL ASPECTS 
OF HSV-1 INFECTION.
i) The Herpesviridae.
Herpesviruses are distributed very widely in nature, their host range extending 
from humans to fish. It is possible that herpes-type viruses are present in all forms of 
eukaryotes. Herpesviruses are therefore of great antiquity and may have evolved their 
basic form long before the evolution of the hosts they currently parasitise.
Almost 100 vimses have been sufficiently well characterised to merit inclusion in 
the family Herpesviridae. Membership of the family is based on three types of 
characteristics: the composition and morphology of the virus particle; aspects of virus 
replication; and more general biological properties. An outline of the defining 
characteristics is found below (adapted from: International Committee on the Taxonomy 
of Viruses, 1981).
1) Properties of the virus particle:
Nucleic acid: a double stranded linear DNA molecule of relative molar mass (Mr) 80- 
150x106.
Proteins: more than 20 structural proteins are found in the virion.
M orphology: the virion is 120-200 nm in diameter and has three components: an 
icosahedral DNA-containing capsid 100-110 nm in diameter; a bilayered membrane 
containing surface projections; and an amorphous layer of variable thickness between 
these two structures called the tegument.
2)Virus replication:
The virus envelope binds to and fuses with the cell membrane, the capsid enters 
the cytoplasm and a nucleoprotein complex is transported to the nucleus. DNA 
replication is nuclear and infectious particles are produced by the budding of the capsid 
through a membrane, usually the nuclear membrane.
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3) Biological properties:
These are very variable but the ability to remain latent in the host is ubiquitous.
The family Herpesviridae is currently divided into three subfamilies the Alpha-, 
Beta-, and Gammaherpesvirinae based on biological characteristics. However these 
divisions are rather subjective. A classification based on objective criteria (such as the 
conservation of genes or gene clusters) has not yet been achieved. The division between 
the Alpha- and Gammaherpesvirinae is primarily according to their host range in vitro and 
the characteristics of their latent infections. That is, alphaherpesviruses generally have a 
wide host range in vitro and their latent infections are established predominantly in 
sensory ganglia whereas the gammaherpesviruses have a narrow in vitro host range and 
latency is generally established in lymphoid tissue. The division between the 
betaherpesviruses and the other groups is based primarily on the length of the 
betaherpesviruses reproductive cycle and their slowness in producing cytopathology in 
cell cultures.
Seven human herpesviruses have been identified. These have been designated 
human herpesviruses 1-7. The first five are also called herpes simplex virus type 1, herpes 
simplex virus type 2, varicella-zoster virus, Epstein-Barr virus, and human 
cytomegalovirus respectively. The results of infection with these viruses range from a 
complete absence of morbidity to life threatening disease.
ii) Medical aspects of HSV-1 infections.
Herpes simplex virus type one is spread in the human population by intimate 
contact when the virus is juxtaposed to mucous membranes or abraded skin. The virus 
replicates at the site of infection and latency is established in dorsal root ganglia (sensory 
ganglia). Most infections are asymptomatic although severe symptoms may result if 
primary infection occurs during adolescence. The virus occasionally causes life 
threatening disease.
HSV-1 is found generally in oral sites, in which case latency is established in 
trigeminal ganglia. It may occur however in genital sites in which case latent infections 
are established in sacral ganglia. The average time of primary infection varies with
socioeconomic status, but is generally during childhood 
(Whitley, 1990). Recurrent disease (following reactivation of virus from latent sites) 
occurs with varying frequency. Re-infection with the same or a different strain of virus 
may also occur. Herpes simplex virus type 2 (HSV-2) is transmitted sexually between 
genital sites.
The most common disease resulting from HSV-1 infection is herpes labialis a 
blistering of the lips around the infection site. The lesions are usually self limiting (that is
2
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immune system limited) except in the immunocompromised host in which case the 
disease may become disseminated widely around the body.
A more serious consequence of infection is herpes simplex keratoconjunctivitis 
following eye infection of which 300,000 cases are diagnosed each year in the United 
States (approximately 1 per 850 members of the population per year) a figure likely to be 
equalled or exceeded around the world. In this case recurrent disease may cause 
opacification of the cornea and, again in the United States, HSV keratoconjunctivitis is 
second only to accidental injury as a cause of corneal blindness (Whitley, 1990).
Infections of the central nervous system are the most serious outcome of HSV-1 
infection. They are the most common cause of sporadic, fatal encephalitis in the US 
(Olson et al, 1967) with a rate of 1 per 200,000 people per year (Whitley et al, 1981). The 
exact symptoms reflect the areas of the brain involved but include a focal encephalitis 
usually localised to the temporal lobe, fever, altered consciousness, bizarre behaviour and 
disordered reasoning. The route by which the virus enters the brain is not known but the 
localised nature of the initial disease makes a blood borne infection unlikely. This being 
the case, direct neuronal transmission via trigeminal or olfactory tracts remains a 
possibility. Innoculation of the virus by the olfactory route in experimental animals has 
led to a fatal encephalitis similar to that seen in humans (Schlitt et al, 1986; 1988).
Antiviral therapy for HSV-1 infection.
Early attempts to develop effective antiviral therapy for HSV were spurred by an 
increasing incidence of genital HSV infections. The majority of effective drugs developed 
so far, and all those currently in clinical use, are nucleoside analogues.
Vidarabine, a purine nucleoside analogue, is used intravenously for neonatal 
herpes simplex infections and for HSV encephalitis, and topically for HSV keratitis. It is 
phosphorylated to its active form by cellular kinases and is therefore effective against 
thymidine kinase negative strains of HSV that are resistant to acyclovir (see below). The 
drug inhibits viral DNA polymerase at concentrations lower than those inhibiting cellular 
polymerases (Shipman et al, 1976) and its mechanism of action is through the viral 
polymerase (Coen et al, 1982). Due to the development of acyclovir the more toxic 
vidarabine is now less commonly used.
Acyclovir is used intravenously or orally for genital herpes, neonatal HSV, HSV 
encephalitis and HSV in the immuno-compromised patient. Acyclovir is a guanosine 
analogue and is very specific for HSV and VZV. The drug is activated specifically to the 
monophosphate by the viral thymidine kinase (TK) and is the first drug to require a viral 
enzyme for activation (Elion, 1982). In addition to this specificity it also has a higher 
affinity for the viral DNA polymerase than cellular DNA polymerases and inactivates the 
viral polymerase by trapping it in a complex with the terminated DNA chain (St Clair et 
al, 1980; Reardon and Spector, 1989). Resistance can develop in vivo by mutations in the
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TK gene or the UL30 (pol) gene (Coen and Schaffer, 1980; Schnipper and Crumpacker, 
1980).
Foscarnet (trisodium phosphonoformate), a pyrophosphate analogue also acting 
through the viral DNA polymerase, has been used to treat recurrent herpes labialis and 
genitalis. It is of particular interest clinically due to its activity against both HIV and 
herpesviruses and is in clinical trials for use with AIDS and AIDS-related complex 
patients (Hirsch and Kaplan, 1990).
A number of triterpenoid compounds have been shown to possess anti-viral 
activity in vitro including activity against herpesviruses (Dargan and Subak-Sharpe, 
1985; Pompei et al, 1979). These include glycyrrhyzin, carbenoxolone sodium and 
cicloxolone sodium. Their mechanism of action involves binding to cell and viral 
membranes and they have been shown to reduce the yield of viral particles produced in 
cell culture systems and also to reduce the viability of these particles (Dargan and Subak- 
Sharpe, 1985). Trials have also shown that carbenoxolone sodium is beneficial for 
treatment of HSV infections in man (Poswillo and Roberts, 1981). Some of these 
compounds may eventually be used regularly for the treatment of HSV infections.
There is likely to be continued interest in the development of antivirals active 
against HSV infections especially due to the seriousness of such infections for immuno­
compromised patients and the appearance of strains resistant to the drugs currently in use.
Immunisation against HSV.
Immunisation to prevent primary or recurrent HSV infection is an attractive 
prospect, but no vaccine is currently in use. Vaccination may be possible by several 
different methods: e.g. a subunit vaccine using purified viral glycoproteins; a killed whole 
virus vaccine or a live attenuated vaccine. As HSV recurs in the presence of high titres of 
antibody a vaccine must stimulate both humoral and cell mediated immunity. 
Considerable effort is being expended, in both academic and pharmaceutical laboratories, 
in the development of effective vaccines.
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II) THE LIFE CYCLE OF HSV-1.
i) Virion structure.
The HSV-1 virion consists of four parts: the icosahedral capsid containing the viral 
genome; a surrounding layer called the tegument; and the envelope, an outer membrane 
studded with the viral glycoproteins. The full complement of virion proteins has not yet 
been established. Early studies suggested that there were approximately 33 virion 
proteins (Heine et al, 1974; Marsden et al, 1976). Of these, 7 have been shown to be 
capsid proteins, probably 10-15 are integral to or strongly associated with the envelope 
and five have been located in the tegument. The remainder are presumably components of 
the tegument or envelope. For a review of the structure of the virion see Dargan, 1986.
The viral genome.
The HSV-1 genome is a linear double stranded DNA molecule whose complete 
sequence has been determined for the Glasgow 17 syn+ strain. The genome of this strain 
comprises 152,260 base pairs with a base composition of 68.3% G+C (McGeoch et al, 
1988a; McGeoch et al, 1985; Davison and Wilkie, 1981; McGeoch etal, 1986; Perry and 
McGeoch, 1988). The molecule may be viewed as consisting of two covalently linked 
segments, the long (L) and short (S) regions, each of which comprises a unique sequence 
flanked by inverted repeats (Sheldrick and Berthelot, 1974). The long repeat (RL) and the 
short repeat (Rs) are distinct. The genome also has a terminal redundancy of 
approximately 400 base pairs termed the a sequence which is present, in the opposite 
orientation, at the joint between the L and S components (Wagner and Summers, 1978). 
See figure 1. Preparations of HSV-1 DNA contain four sequence-orientation isomers 
generated by inversion of the unique segments relative to j  the repeats (Hayward et al, 
1975; Delius and Clements, 1976; Wilkie, 1976). The significance of this genome 
organisation is unknown but may be a consequence of the mode of DNA replication. One 
genome isomer has been chosen arbitrarily as the prototype for purposes of representation.
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TRl U l
a
“ i—
oriL
IRl IRs
C O
Us TRs
d  oris oris a
Figure 1. The genome of HSV-1 is shown in the prototype orientation. Unique sequences 
are represented by a single line and repeated sequences as boxes. The following features 
are labelled: L: long component; S: short component; a and a': the a sequence in its two 
orientations; TR l and IRl: the terminal and internal long repeats respectively; TRs and 
IRs: the terminal and internal short repeats respectively; U l : the long unique region; Us: 
the short unique region; oriL and oris: the origins of replication located within the long 
and short components respectively. After McGeoch et al, 1988a.
It was originally proposed (McGeoch et al, 1988a) that the genome contained 72 
open reading frames encoding 70 distinct proteins. Only a proportion of these genes were 
predicted without any previous knowledge of coding potential. Many genes had 
previously been located approximately or precisely through the use of ts mutants, 
intertypic (HSV-1 x HSV-2) recombinants and mRNA mapping. However the availability 
of the complete genome sequence has greatly facilitated research on HSV-1 and related 
herpesviruses. Many of the predicted open reading frames are dispensable for virus 
growth in tissue culture although they are doubtless required for survival in the natural 
state. Four more distinct genes have since been proposed which encode: a putative 
latency associated transcript (LAT) product (2 copies, Stevens et al, 1987; Wagner et al, 
1988a; Wagner et al, 1988b); UL26.5 (Liu and Roizman, 1991a); UL49A or UL49.5 
(Barker and Roizman, 1992; Barnett et al, 1992); and ICP34.5 (2 copies, Ackermann et al, 
1986b; Chou and Roizman, 1986).
The genome also contains three origins of DNA replication: oris located in the 
short repeat and oriL located near the middle of U l . These were located by the following 
workers: (Stow, 1982; Mocarski and Roizman, 1982a; Stow and McMonagle, 1983; 
Spaete and Frenkel, 1982; Weller et al, 1985). See HSV DNA replication section.
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The capsid.
The HSV-1 capsid appears in the electron microscope as an icosahedron with 150 
hexavalent and 12 pentavalent capsomeres (Wildy et al, 1960). The capsid appears to 
have no internal structure (Gibson and Roizman, 1972; Schrag et al, 1989; Booy et al,
1991).
Mature capsids from purified virions comprise six proteins of which five were 
identified by Gibson and Roizman (1972) - VP5, VP19C, VP2i^ VP23 and VP24, and a 
sixth by Heilman et al (1979) and Cohen et al (1980) - pl2 or VP26. One form of 
immature capsid contains in addition a seventh protein VP22a (see later). Firm gene 
assignments have been made for all but one of the capsid proteins (see table 1).
Table 1. Capsid proteins.
Protein Molar mass (kD) Gene
VP5 155 UL19
VP19C 53 UL38
VP21 45 UL26?
VP22a 38 UL26.5
VP23 36 UL18
VP24 24 UL26
VP26 12 UL35
References for gene assignments are as follows: VP5: Costa et al, 1984; Davison and 
Scott, 1986b. VP19C and VP23: Rixon et al, 1990. VP21 (proposed as C-terminus of 
UL26) and VP24 (N-terminus of UL26): Davison etal, 1992. VP22a: Liu and Roizman, 
1991b. VP26: McNabb & Courtney, 1992.
The functions of capsid proteins have not been defined with the exception of VP5 
the major capsid protein, which is the major component of the capsid hexamers (Vernon et 
al, 1981). VP5, VP19C and VP23 have been shown to be located on the surface of the 
capsid while VP21, VP22a and VP24 are internal (Newcomb and Brown, 1989; 1991).
\* It should be noted that VP21 is actually present only in immature capsids 
| (Booy et al., 1991).
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(2) Roop et al., (1993) ,
f a  Glycoprotein M is also found in the virion: Baines & Roizman, (1993); MacLean et a l, 
^ (  1993).
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The virion envelope.
The envelope of the HSV-1 virion consists of a lipid membrane studded with viral 
proteins, mostly glycoproteins. Prominent spikes of at least three different types have 
been seen on the surface of virions (Wildy et al, 1960; Stannard et al, 1987). Each type of 
spike differed in size, shape and distribution in the virion membrane. Glycoproteins B, C 
and D were shown to be constituents of these spikes using monoclonal antibodies, each 
glycoprotein being present in only one type of spike (Stannard et al, 1987).
The number of envelope proteins is not finally established but there are at least 9
viral glycoproteins all of which are present in the virion envelope: gB, gC, and gD (Spear,
1976); gE (Baucke and Spear, 1979; Para et al, 1980); gG (Marsden et al, 1976; 1984;
Roizman et al, 1984; Richman et al, 1986; Ackermann et al, 1986a; Frame et al, 1986a);
gH (Buckmaster et al, 1984, Showalter e^al, 1981); gl (Johnson and Feenstra, 1987;
Longnecker et al, 1987; Johnson et al, 1988); gK (Hutchinson et al, 1992b; Ramaswarmy
* CbO)and Holland, 1992); and gL (Hutchinson et al, 1992a). Glycosylation of HSV-1h ^
glycoproteins is predominantly N-linked (Spear, 1985; Pizer et al, 1980) although O- 
linked glycosylation does occur (Oloffson etal, 1981; Wenske and Courtney, 1983). In 
particular glycoprotein G of HSV-2 is heavily O-glycosylated (Serafini-Cessi et al, 1985). 
Cellular enzymes are thought to be responsible for these modifications. The role of 
carbohydrate moieties in glycoprotein function has not been defined. However, 
glycosylation plays some role in infectivity as virions produced in the presence of 
tunicamycin, which prevents N-linked glycosylation, are not infectious. Virions 
containing partially glycosylated glycoproteins are infectious (Kousoulas et al, 1983).
In addition to roles in attachment and penetration (see later) several of the viral 
glycoproteins exhibit other interesting properties. Glycoprotein C binds to the C3b 
fragment of the third component of complement (Friedman et al, 1984; Eisenberg et al, 
1987; McNeamey et al, 1987). Also gC can accelerate the decay of the C3 convertase of 
the alternative complement pathway (Fries et al, 1986). This activity could account for 
the protection against complement-mediated damage to virions and infected cells 
observed when gC is present but not when it is absent (Harris et al, 1990; McNearney et 
al, 1987). Although these results, obtained in vitro, suggest a role for gC in protecting 
virions and infected cells from the immune system, this has yet to be demonstrated in 
vivo.
An antibody binding activity is induced in cells by HSV-1 infection (Watkins, 
1964). This IgG Fc binding activity was partially purified from infected cells and virions 
by Baucke and Spear (1979) and Para etal (1980) and shown to be a glycoprotein which 
was designated gE. The gene encoding gE was mapped to genome coordinates 0.924 - 
0.951 (Para et al, 1982; Hope et al, 1982; Lee et al, 1982), which corresponds to gene 
US8 (McGeoch et al, 1985). Subsequently another glycoprotein was identified that,
8
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1993; MacLean et al., 1993.
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together with gE, bound IgG (Johnson and Feenstra, 1987; Johnson et al, 1988) and this 
was designated gl (Longnecker et al, 1987). Its gene was identified as US7.
No specific in vivo role for Fc binding has been demonstrated. In fact the Fc 
portion of antibody may not even be the relevant ligand, since homologous domains are 
highly conserved throughout the immunoglobulin superfamily. However, Adler et al 
(1978) found that pre-incubation of HSV-1 infected cells with non-immune IgG greatly 
reduced complement-mediated and cell-mediated lysis of the cells. This suggests a role 
for the Fc-binding complex in protecting virions and infected cells from immune attack.
With regard to non-glycoprotein envelope components, a number of genes were 
predicted by McGeoch et al (1988a) to encode membrane spanning proteins: UL3, UL10, 
UL20, UL34, UL43, and UL45. These are either singly or multiply hydrophobic in 
portions of their predicted amino acid sequence and may represent virion envelope 
constituents. UL3 and UL43 also have potential N-linked glycosylation sites. The UL45 
gene product has been shown to be present in virions (McLean, 1990) but there have been 
no reports whether any of the other proteins are present.
The tegument.
The tegument is defined as the region between the capsid and the envelope and 
comprises approximately 65% of the virion volume (data from Schrag et al, 1989). It 
contains a number of proteins important to the virus life cycle. The total number of 
proteins present is unknown. Seen in the electron microscope the tegument has no 
apparent structure but its size is consistent between preparations and is independent of cell 
type leading to the conclusion that this feature is determined by the virus (McCombs et al, 
1971). It is not known whether the tegument has any structure but the constituents may 
have some ability to self-associate. This idea is supported by analysis of the recently 
discovered L particles (Szilagyi and Cunningham, 1991) which consist of tegument and 
envelope. Disruption of the L particles with detergent leaves amorphous blobs of 
material thought to comprise tegument proteins alone (McLauchlan and Rixon, 1992).
To date five proteins have been identified in the tegument including the a-trans 
inducing factor (aTIF, also known as Vmw65 or VP16), the product of gene UL48 (Post 
etal, 1981; Cordingley et al, 1983; Batterson and Roizman, 1983; Campbell etal, 1984; 
Pellett et al, 1985; and Dalrymple et al, 1985); VHS the virion host shut off protein the 
product of gene UL41 (Sydiskis and Roizman, 1966; Fenwick and Walker, 1978; Kwong 
et al, 1988; McGeoch et al, 1988a); Vmw 81/82 the product of gene UL47 (McLean et al, 
1990); and a lOkD phosphoprotein, the product of gene US9 (Frame etal, 1986b).
A number of investigators have reported protein kinase activity associated with the 
tegument or capsid of HSV-1 (Rubenstein et al, 1972; Stevely et al, 1985; Lemaster and 
Roizman, 1980) however the activities reported had very diverse properties and it was 
uncertain whether they were encoded by the virus. The first viral protein kinase to be
\
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identified (the US3 gene product) appears to be distinct from the virion associated protein 
kinase (Frame et al, 1987; Purves et al, 1987). The UL13 gene product was predicted to 
be a serine and threonine specific protein kinase on the basis of its amino acid sequence 
(Smith and Smith, 1989). The gene has homologues in all three subgroups of the 
herpesviruses. It has since been shown that UL13 (a virion protein) is a protein kinase and 
that its major reaction is autophosphorylation (Cunningham et al, 1992; Overton et al,
1992).
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Entry of HSV-1 into cells occurs by attachment of the virion to cell surface 
receptors followed by penetration via /?H-independent fusion of the viral and cellular 
membranes (Morgan et al, 1968; Para et al, 1980; Fuller and Spear, 1987; Wittels and 
Spear, 1990). The nucleocapsid and the tegument components then enter the cell 
cytoplasm.
Initial attachment of the virus occurs through binding of viral glycoprotein gC to 
cell surface heparan sulfate proteoglycans. A number of lines of evidence support this 
conclusion:
1) Heparan sulfate is required for efficient entry of virus as cells enzymatically stripped of 
heparan sulfate or unable to produce heparan sulfate are very difficult to infect with 
HSV-1. Virions also bind to heparin (a compound structurally very similar to heparan 
sulfate) and heparin and heparin binding proteins also inhibit HSV-1 adsorption and 
plaque formation (WuDunn and Spear, 1989; Herold eta l, 1991; Shieh etal, 1992).
2) Herpes simplex virus has a very broad host range in vitro suggesting that any receptor 
must be both ubiquitous and highly conserved, criteria satisfied by heparan sulfate. In 
addition no other receptor has been demonstrated.
3) Virions lacking gC bind more slowly to cells although they remain infectious 
'(Langeland et al, 1990; Herold e ta l , 1991) and gC is the HSV-1 glycoprotein with the 
strongest heparin binding activity (Herold et al, 1991).
4) gC forms part of the longest spikes seen projecting from HSV-1 virions (Stannard et al, 
1987).
The role of the C3b binding activity of gC in attachment is uncertain but the 
functions are likely to be unrelated. gC" virus can still adsorb to cells via heparan sulfate. 
This and the fact that gB binds to heparin in affinity chromatography experiments 
suggests that this secondary binding is mediated by gB (Herold et al, 1991). Comparison 
of the properties of gC" gB+ and gC‘ gB“ viruses should clarify this point. gD also 
appears to have some role in adsorption in addition to its established role in penetration 
(Fuller and Spear, 1985).
Earlier reports (Kaner et al, 1990; Baird et al, 1990) that the high affinity receptor 
for basic fibroblast growth factor could serve as a portal of entry for HSV-1 have not been 
confirmed (Shieh et al, 1992; Mirda etal, 1992; Muggeridge etal, 1992).
Penetration of the cell by fusion of the viral and cellular membranes follows 
adsorption and is probably mediated by at least 3 components of the virion gB, gD and 
gH, each of which is required for virus replication in tissue culture (Sarmiento et al, 1979; 
Cai et al, 1987; 1988; Ligas and Johnson, 1988; Desai etal, 1988). Evidence that gB, gD 
and gH are all required for penetration comes from studies of mutants producing virions
11
^Xs gH and gL form a functional unit and neither can be included in the virion alone, it 
may be said that both are required for penetration.
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lacking one of these protein^ All three types of virions were able to adsorb to cells as 
strongly as wild-type virus but no plaques were produced (Cai et al, 1987; 1988; Desai et 
al, 1988; Fuller and Spear, 1987; Campadelli-Fiume eta l, 1988; Fuller et al, 1989; Ligas 
and Johnson, 1988; Sarmiento et al, 1979). Addition of polyethylene glycol, a chemical 
fusogen, results in the production of a much greater number of plaques by these viruses. 
The precise roles of gB, gD and gH in fusion are not known. Fuller and Lee (1992) 
suggest that gD and gH are involved in the initiation of fusion.
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Upon fusion of the viral and cellular membranes the viral nucleocapsid and the 
tegument components enter the cell. The nucleocapsid is transported to the nucleus which 
the genome enters, and the virion host shut-off (VHS) function is activated.
Release of the tegument components of the virion into the host cell cytoplasm 
allows the virion host shut-off protein to begin functioning. A rapid inhibition of host 
protein synthesis (Fenwick and Walker, 1978; Nishioka and Silverstein, 1978; Smibert et 
al, 1992) is accompanied by degradation of host mRNA (Fenwick & McMenamin, 1984; 
Schek and Bachenheimer, 1985). The isolation of shut-off defective mutants showed that 
the vhs gene mapped to gene UL41 (Kwong et al, 1988). In addition to the expected 
effects, inactivation of the vhs gene was associated with increased stability of viral 
mRNAs (Kwong et al, 1988; Oroskar and Read, 1989). Degradation of mRNAs is non­
specific, affecting host and viral species equally (Nishioka and Silverstein, 1978; Oroskar 
and Read, 1989) suggesting that VHS operates by a mechanism which involves 
stimulation of the cellular mRNA degradation machinery.
Nucleocapsid transport to the nucleus is mediated by microtubules (KWstensson et 
al, 1986) presumably using host transport mechanisms. Release of the viral DNA into the 
nucleus occurs by an unknown mechanism involving the product of gene UL36 (predicted 
molecular mass 336kD) a function identified using a temperature sensitive mutant 
(Batterson et al, 1983).
iv) Transcription In the infected cell.
Following infection of cells with HSV-1, transcription of cellular genes is greatly 
reduced whilst transcription of viral genes is strongly activated (Everett, 1987; Smibert 
and Smiley, 1990). The mechanism by which this process operates is complex and not 
fully understood. For example a cellular gene may behave differently to an identical gene 
and promoter combination placed in the viral genome (Smibert and Smiley, 1990). 
However, viral genes inserted in the cell genome are activated by infecting virus (Sandri- 
Goldin et al, 1983) and plasmid-borne cell or viral genes can be transactivated by viral 
products (Everett, 1984).
Viral genes are transcribed in the nucleus by cellular RNA polymerase II 
(Costanzo et al, 1977; Ben-Zeev and Becker, 1977). Various classifications of viral genes 
have been proposed based on their time of synthesis or presumed controls on their 
transcription (Jean et al, 1974; Honess and Roizman, 1974). However, only two classes 
of viral genes have been defined by experimental criteria: the immediate early (IE) or a  
genes and the true late genes. Transcription of IE genes is not inhibited by addition of 
protein synthesis inhibitors (Honess and Roizman, 1974). Transcription of true late genes
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is greatly reduced by the inhibition of DNA replication, 95% reduction being suggested as 
a working definition (Johnson et al, 1986). These differences presumably reflect different 
controls on the transcription of these genes (see below). The remainder of HSV-1 genes 
have been called early, delayed early, leaky late, p, y  and a number of other names; but 
they do not form a well defined class as each is expressed at different times after infection. 
For convenience they will be referred to here as early genes.
Transcription of IE genes.
The immediate early proteins and genes of HSV-1 are listed in table 2, with 
alternative nomenclatures. Transcription of IE genes does not require prior protein 
synthesis, but is stimulated by the virion tegument component Vmw65 (aTIF or VP16) 
(Post et al, 1981; Batterson and Roizman, 1983; Campbell et al, 1984; Pellett etal, 1985; 
Dalrymple et al, 1985). When released into the infected cell Vmw65 complexes the
Table 2: Nomenclature of immediate early (IE) proteins and genes. 
Proteins Molar mass Genes
cellular transcription factor Oct 1 causing it to bind to the sequence TAATGARAT which 
is found in the regulatory regions of all IE genes (Mackem and Roizman, 1982; Kristie 
and Roizman, 1984; Preston, C.M. etal, 1984; Gaffney et al, 1985; O'Hare and Gooding, 
1988; Preston, C.M. et al, 1988). Thus activation of IE transcription involves recognition 
of class-specific cis-acting regulatory signals that are distinct from basal promoter 
elements. In addition to the genes just mentioned, UL39 (encoding the large subunit <of 
the HSV-1 ribonucleotide reductase) is regulated partly as an immediate early gene 
(Watson etal, 1979; Sze and Herman, 1992)
In addition to activation by Vmw65, IE genes are subject to autoregulation. IE175 
down regulates its own promoter by binding across the cap site and may down regulaite 
the promoters of other IE genes as well (O'Hare and Hayward, 1985a; Deluca and 
Schaffer, 1985; Everett, 1987).
IE175 (Vmwl75, ICP4) 
IE110 (VmwllO, ICPO) 
IE68 (Vmw68, ICP22) 
IE63 (Vmw63, ICP27) 
IE12 (Vmwl2, ICP47)
(kD)
175
110
68
63
12
IE175 (IE3, a4) 
IE110 (IE1, aO) 
US1 (IE4, a22) 
UL54 (IE2, a27) 
US12 (IE5, a47)
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Transcription of other genes; the role of the immediate early gene products.
HSV-1 IE gene products are involved in transactivation of early and true late 
promoters (see below) but the mechanisms of activation remain unclear as the promoters 
do not contain obviously conserved class-specific sequences analogous to the IE 
TAATGARAT (reviewed in Everett, 1987). Some early genes are partially dependent on 
DNA replication for their transcription, while true late genes are completely or virtually 
completely dependent on i t  DNA replication induces a cis-acting modification of the 
template that allows true late genes to be transcribed (Johnson and Everett, 1986; 
Mavromara-Nazos and Roizman, 1987). Expression of true late genes appears also to be 
influenced by sequences downstream of the gene's TATA box (Mavromara-Nazos and 
Roizman, 1987; Kibleretal, 1991).
Transcription of both early and true late genes during infection is dependent on the 
continuous presence of functional IE175 the major HSV-1 transcriptional regulator 
(Preston, 1979; Dixon and Schaffer, 1980; Watson and Clements, 1980). IE175 has also 
been shown to transactivate the transcription of early and true late gene products in 
transfection assays (Gelman and Silverstein, 1986; O'Hare and Hayward, 1985a;1985b; 
Quinlan and Knipe, 1985). IE175 binds to DNA and a consensus sequence has been 
proposed (Faber and Wilcox, 1986) although the protein can bind to unrelated sites 
(Imbalazano et al, 1990; Tedder et al, 1989). The region of the protein involved in DNA 
binding has been located (DeLuca and Schaffer, 1988; Paterson and Everett, 1988; Wu 
and Wilcox, 1990). Transactivation by IE175 may be mediated by direct interaction of 
the protein with DNA or interaction through a cellular protein. IE 175 may alternatively 
have multiple modes of action (Shepard and DeLuca, 1991a; 1991b; Imbalazano et al, 
1990; Smiley etal, 1992).
IE 110 is a powerful and wide ranging activator of transcription in transfection 
based assays (Everett, 1984; O'Hare and Hayward, 1985b; Quinlan and Knipe, 1985; 
Gelman and Silverstein 1985) and was therefore expected to play a crucial role in virus 
growth. However a virus with a deletion in the IE 110 gene was viable, the only apparent 
phenotype being poor growth at low multiplicities of infection (Stow and Stow, 1986). It 
was later found that purified IE110 protein did not bind stably to DNA in solution 
although the sequence of the protein suggests the presence of a highly conserved zinc 
finger domain (Everett et al, 1991). Despite this IE110 is the major transactivator of gene 
UL39 coding for the large subunit of ribonucleotide reductase (Sze and Herman, 1992).
Temperature-sensitive mutants with lesions in the gene for IE63 protein were 
shown to exhibit altered levels of IE and true late transcripts (increased and decreased 
respectively) by Sacks et al (1985). However investigation of the effects of IE63 on 
viral transcription in transfection experiments showed a limited influence (Everett, 1986). 
That is, IE 63 was active only on some promoters and then only in the presence of IE175 
and IE110. IE63 has recently been shown to act at least in part post transcriptionally,
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affecting mRNA processing (Smith et al, 1992; McLauchlan et al, 1992). The other IE 
gene products (IE68 and IE12) have not been shown to have any effect on the 
transcription of viral genes.
v) Viral DNA replication.
Following transport of the nucleocapsid to the nucleus the viral DNA is replicated 
in the nucleus starting at approximately 3 hours after infection. As this happens cellular 
chromatin is displaced to the edge of the nucleus (Munk and Sauer, 1964; Rixon et al,
1983). Replication of viral DNA is described in more detail in section IV.
Multiple reduplication of the nuclear membrane is also seen (Nii et al., 1968).
vi) Virion assembly.
HSV-1 virions are assembled by packaging the viral genome into preformed 
capsids in the nucleus of the infected cell. The nucleocapsids then bud through the 
nuclear membrane acquiring tegument and an envelope.
Encapsidation of the genome.
Three forms of capsids have been seen in HSV-1 infected cells. Large-cored 
capsids (sometimes referred to as type B) have a large electron-translucent core and do not 
contain DNA. Small-cored capsids (type C) have an electron-dense core made up of
DNA. Empty capsids (type A) have no internal structure. Large-cored capsids are
probably scaffold containing species as removal of the internal structure of large-cored 
capsids is required for the packaging of DNA (Ladin et al, 1980; Preston et al, 1983; 
Addison et al, 1984). After DNA packaging the complete capsid is then enveloped. 
Empty capsids may be capsids that have lost their scaffold but not yet acquired DNA or a 
dead-end species and not in the developmental pathway. The scaffold of large-cored 
capsids is believed to be composed of protein VP22a (Newcomb and Brown, 1989;
1991). The processing of VP22a by the UL26 protease is required for capsid maturation 
(Preston et al, 1983; Rixon etal, 1988; Liu and Roizman, 1991b; Preston etal, 1992).
Herpes simplex virus DNA replication produces high molecular mass 
concatenated genomes which must be processed into single genomes for packaging. The 
a sequence which is present at genome termini and at the joint between the L and S 
segments of the genome contains the cleavage and packaging signals. If extra copies of 
this sequence are inserted into the viral genome and cells are infected with the mutant the 
progeny virus includes novel forms resulting from cleavage and recombination at the new 
a sequence (Smiley etal, 1981; Mocarski and Roizman, 1982a; Varmuza and Smiley,
1985). Defective viral genomes also require the a sequence (along with an origin of
16
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replication) if they are to propagate in virus stocks (Stow et al, 1983; Deiss and Frenkel, 
1986). The structure of the a sequence is shown in figure 2.
ra
D R i  Ub DR2 DR4 U c D R i
Figure 2. Structure of the a sequence.
The junction region of the viral genome is shown, the dotted lines representing IRL 
and IRs (left and right respectively). The following elements are present:
Ub unique sequence of 64 bp containing p a d  (see below).
Uc unique sequence of 58 bp containing pac2.
DRI 17-21 bp direct repeat shared between adjacent a sequences. Genome termini if
ligated would share one DRI element between them. Strain F has one 3' 
overhanging nucleotide at the S terminus and the remainder of the DR 1 element at 
the L terminus. (Mocarski & Roizman, 1982b; Mocarski eta l., 1985).^
DR2 directly repeated 12 bp element present in 1-22 copies.
DR4 repeat element present in present in 1-3 copies.
Data for this figure is taken from: Davison and Wilkie, 1981; Mocarski and Roizman, 
1981.
Despite the highly variable nature of the a sequence between virus strains two 
highly conserved regions have been noted. These are called p a d  and pac2 and are 
required for packaging of HSV DNA (Deiss et al, 1986). Analysis of a complex formed 
at the a sequence suggested that three proteins were involved (Chou and Roizman, 1989). 
These were the viral alkaline exonuclease (Hay et al, 1971); ICP1, the product of gene 
UL36; and an unidentified 140 kD protein. While the exonuclease bound non-specifically 
to viral DNA, ICP1 and the 140 kD protein formed a complex that bound specifically to a 
combination of the pac2 and DRI portions of the a sequence. This suggests that these 
proteins are involved in recognition and packaging of viral DNA. Additional evidence for 
the involvement of the alkaline nuclease in packaging comes from a null mutant. When 
grown on cells that did not express the nuclease this mutant gave very poor yields of virus 
despite producing large quantities of viral DNA and late proteins (Weller et al, 1990).
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Envelopment and the release of mature virions.
Nucleocapsids associate with regions of the inner nuclear membrane modified by 
viral glycoproteins and then bud into the perinuclear space (Darlington and Moss, 1968; 
Morgan et al, 1959; Nii et al, 1968). Two routes have been proposed for the movement of 
virus to the cell surface from the perinuclear space (Morgan et al, 1959; Stackpole, 1969; 
Johnson and Spear, 1982; Spear, 1985). Enveloped HSV-1 particles may be carried to the 
endoplasmic reticulum and the Golgi apparatus and then to the plasma membrane in 
transport vesicles similar to those which carry membrane and secreted proteins. 
Prevention of budding from the Golgi apparatus with the ionophore monensin completely 
inhibited the production of extracellular virus, causing virions to accumulate in 
cytoplasmic vacuoles derived from the Golgi (Johnson and Spear, 1982). Alternatively, 
capsids may lose their envelope at the outer nuclear membrane and be re-enveloped into 
cytoplasmic vesicles before transport to the cell surface. Non-enveloped capsids seen in 
the cytoplasm and apparently budding into cytoplasmic vesicles may be produced by this 
route (Nii et al, 1968; Rixon et al, 1992).
vii) Latency.
Herpes simplex virus is able to persist in its host despite an active immiune 
response due to its ability to become latent. Viral latency is defined as a state in which the 
genome of the infecting virus is present but infectious particles are not produced except 
during intermittent periods of reactivation (Ahmed and Stevens, 1990). HSV latency is 
established in the sensory ganglia which innervate the site of initial infection. After the 
virus replicates at the periphery the viral nucleocapsid is transported to the ganglion by 
retrograde axonal transport (Cook and Stevens, 1973; Para et al, 1980; Whitley, 1990;
. DNA
Lycke et al, 1984). There vir<x\Ais harboured in sensory neurons (Cook et al, 1974; 
Kennedy et al, 1983; McLennon and Darby, 1980).
Examination of HSV DNA in latently infected neurons showed that the ends of the 
genome were covalently joined both in a mouse model of the latent state and in hum ans 
(Rock and Fraser, 1983; 1985; Efstathiou et al, 1986). It was also shown that in the 
mouse, the DNA existed in an extrachromosomal form (probably a circle) and that it was 
associated with nucleosomes (Mellerick and Fraser, 1987; Deshmane and Fraser, 1989). 
Efstathiou et al (1986) estimated that latently infected human ganglia contained 0.01—0.1 
HSV genomes per cell although, of course, not all cells are infected. By scoring neunons 
expressing viral latency associated transcripts (see below) to establish the proportion of 
neurons infected, quantitating viral DNA by slot blot, and assuming that 10% of ganglion 
cells are neurons Stevens (1989) estimated that approximately 20 genomes were presient 
per latently infected neuron in mouse spinal ganglia.
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Only a small part of the HSV genome is transcribed in the latent state. The 
transcribed region was first identified by Stevens et al (1987) in experimentally infected 
mice and its products were termed the latency associated transcripts or LATs. LATs were 
subsequently detected in human ganglia and in other experimental systems (Croen et al, 
1987; Steiner et al, 1988; Wechsler et al, 1988; Rock et al, 1987; W agner et al, 1988b). 
The transcription pattern of the LAT region is complex and not fully understood. 50-90%  
of LATs are an approximately 2 kb species. A minor 1.5 kb species and various other 
minor or unstable forms have also been detected (figure 3).
1 kb
IRl a '  IRs
 1 •........:........■.. II..... ............... ......I-----------
<  < ------------
IE110 34.5 IE175
2kb  ^
1.5kb
8.3kb ......................................................
Figure 3. Transcripts from the LAT region of HSV-1. Transcripts found in latently 
infected cells are shown below a representation of the IR i-U l junction of HSV-1 DNA 
(unbroken line —  major species; dashed line — minor species). The acute phase 
transcripts of genes IE110 ,1CP34.5, and IE175 are shown for comparison. A comparable 
arrangement exists in the other long repeat.
LATs are located predominantly in the nucleus and are not polyadenylated 
(Spivak and Fraser, 1987; Wagner et al, 1988b). It has been estimated that each latently 
infected murine neuron contains 2 x l0 4 -  5 x l0 4 LATs in total (W agner et al, 1988a). 
Promoter elements for RNA polymerase II were not apparent in the DNA sequence 
immediately upstream of the major LAT, the first LAT to be discovered. This led to a 
search for the promoter and a proposal that the major LAT was actually a stable irtron 
spliced from the largest (c.8.3 kb) LAT, transcribed from a promoter 600-800 base pairs 
upstream of the 5’ end of the major LAT (Dobson et al, 1989; Batchelor and O'Hare, 
1990; Zwaagstra et al, 1989; Farrell et al, 1991). Two open reading frames have ^een 
postulated in the major LAT and a protein product of one of them was reported in neurons
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latently infected in vitro (Wagner et al, 1988a; Doerig et al, 1991). The function of this
putative gene product has yet to be identified.
LATs are antisense to the mRNA for the transactivating gene product IE 110.
Therefore a function for them might be to down regulate gene expression to induce a
latent infection. However a number of experimenters have shown that LATs are not
required for the establishment or maintenance of latency (Javier et al, 1988; Steiner et al,
1989). Experiments to determine if LATs are required for reactivation from latency have
given conflicting results (Leib et al, 1989; Trousdale et al, 1991; Block et al, 1990; Ho
and Mocarski, 1989). Trousdale et al used in vivo reactivation from rabbit eyes as an
assay. They found that reactivation occurred in only 4% of eyes infected with LAT
negative virus whereas reactivation occurred in 70% of eyes infected with wild type virus.
They also found that significantly more wild type than mutant virus reactivated if explant
co-cultivation was used as an assay. Experiments showing no difference between LAT+
and LAT- virus have used only explant co-cultivation as an assay. It is possible that due
to the complex nature of the LAT region of the genome, the mutant viruses used in these
studies behaved differently in latently infected neurons.
A previously unidentified gene RL1 (ICP34.5) has recently been demonstrated in
the long repeats of the HSV-1 genome (Ackermann et al, 1986b; Chou and Roizman,
1986). This gene has a strong influence on the neurovirulence of HSV-1; viruses lacking
both copies of the gene have their neurovirulence reduced by a factor of 105 despite
showing unimpaired growth in vitro (Taha et al, 1989a; 1989b). The gene shows strong
homology over part of its sequence to a gene, MyDl 16, associated with differentiation of
myeloid cells (McGeoch and Barnett, 1991). Comparison of the growth of wild type and 
on®.
RL1 deficient virus in neuroblastoma ce 11^  suggests that RL1 may prevent the shutoff of 
protein synthesis that seems to be triggered in these cells in its absence (Chou and 
Roizman, 1992). These results suggest that ICP34.5 may be important during latency of 
HSV. However MacLean etal {1991) found that mutants of HSV-2 lacking RL1 behaved
A
identically to wild type virus in establishing latency in mice and reactivating when 
infected ganglia were explanted, j However, HSV-1 mutants in RL1 have impaired 
reactivation (Robertson et al., 1992) and therefore it appears that HSV-1 and -2 behave 
differently in this respect.
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In the forty years since the double helical structure of DNA was proposed, 
considerable progress has been made in discovering how DNA is replicated. In almost all 
organisms the main features of the process are identical. Replication initiates at specific 
DNA sequences called origins and proceeds by the copying of the separated strands of the 
duplex. Nucleotides complementary to the existing sequence are added by a DNA 
polymerase, the new nucleotide chain being synthesised in the 5*—3* direction by the 
addition of nucleotide monomers. DNA polymerases can extend existing polynucleotide 
chains but not begin the synthesis of new ones and therefore a mechanism for priming 
polymerisation is required. Priming generally involves the synthesis, by a dedicated 
primase, of a short RNA chain which is then extended by the DNA polymerase. As 
replication proceeds away from an origin the duplex is opened ahead of the polymerase by 
a helicase enzyme. This results in the formation of a replication fork (see figure 4). 
Superhelical strain induced in the DNA by this process is relieved by a topoisomerase 
enzyme which nicks and rejoins one strand of the DNA ahead of the replication fork 
allowing untwisting to occur. To avoid lengthy exposure of DNA in a vulnerable single 
stranded form, both strands of the duplex must be copied in the same overall direction as 
the replication fork advances. As nucleotide polymerisation can proceed only in the 5 -3 ’ 
direction, one strand is copied in short sections as it is exposed by the action of the 
helicase, while the other is copied continuously. Copying of the two strands is probably 
coordinated by a multiprotein complex called a replisome. This is proposed to contain the 
polymerases acting on the two strands, together with the helicase, the primase for repeated 
initiation on the discontinuously synthesised strand, and other accessory factors.
Table 3. The components of some well characterised replication systems.
Function E. coli T7 T4 SV40
Initiation dnaA, RNA pol T7 RNA pol ? T antigen
Helicase dnaB gp4 gp41 T antigen
Primase dnaG gp4 gp61 pol a  primase
Polymerase
Core pol III (a, e, 0) gp5 gp43 pol a , pol 5
Accessory subunits p, y complex, x thioredoxin gp44,62,45 PCNA, RF-C
:ssDNA-binding SSB gp2.5 gp32 RF-A
Swivel gyrase T4 topo topo I or topo II
Decatenation gyrase ? ? topo II
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Figure 4. Cartoon of a replication fork. Parental DNA is represented by thin lines 
and newly synthesised DNA by thick lines. A polymerase with accessory factors 
(rectangle) synthesises the leading strand as the parental duplex is opened by the 
helicase (triangle). On the lagging strand, a polymerase (square) completes a 
fragment of newly synthesised DNA. A primase (circle) synthesises a primer 
(dotted line) for polymerase to extend as the next fragment. All regions of single 
stranded DNA would be covered by single stranded DNA-binding protein (not 
shown). In reality all the proteins may form a single complex, the DNA bending to 
allow this. Topoisomerase and ligase enzymes are not shown.
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The whole process may be visualised as a machine drawing in duplex DNA and extruding 
two new duplexes at its far side. There is even some evidence that the replisome is 
attached to the nuclear matrix in some or all organisms and is therefore stationary relative 
to the cell as a whole while the DNA is drawn through the complex. Primers are removed 
in the course of chain elongation and the ends of the new chains are joined by the enzyme 
DNA ligase. Disentangling of the new duplexes by a topoisomerase completes 
replication. The details of the process, as determined in various organisms, will be 
described in more detail below. Table 3, listing the components of some well 
characterised replication systems, is provided for reference. A more complete description 
of DNA replication may be found in Komberg and Baker, 1991.
i) Initiation.
Studies of prokaryotes, lower eukaryotes and eukaryotic viruses have revealed 
considerable similarity in the basic mechanisms of initiation. Three events must occur 
sequentially for initiation of DNA replication. These are:
i) binding of a protein to specific DNA sequences in the origin;
ii) local opening of the helix by this protein, a process that consumes energy;
iii) loading of a helicase to further open the DNA and allow priming and the assembly of 
the replication machinery.
Initiation in prokaryotes.
Initiation of DNA replication in E. coli is understood better than initiation in any 
other organism. In vivo, replication in E. coli begins only at oriC the unique chromosomal 
replication origin. Deletion analysis has defined the minimal size of OriC as 245 bp. The 
essential region contains four 9 bp boxes and three adjacent 13 bp boxes which are highly 
conserved. These boxes, where substitutions are not tolerated, are separated by portions 
of DNA of fixed length but random sequence (Asada et al, 1982; Oka et al, 1984). 
Initiation begins with the recognition of the 9 bp boxes by dnaA protein (Fuller et al,
1984). Twenty to forty monomers of dnaA bind cooperatively to the origin, protecting 
approximately 200 bp of DNA from nuclease attack. The helix adjacent to the dnaA 
boxes is then opened by dnaA protein (Bramhill and Komberg, 1988). Opening of the 
helix allows loading of the dnaB helicase from a dnaB.dnaC.ATP complex, forming the 
pre-priming complex (Funnell et al, 1987). HU, a double stranded DNA-binding protein, 
is also required for the formation of the pre-priming complex, probably to stabilise a 
preferred bend in the DNA. The DNA is further opened by the helicase so that replication 
can commence (Baker et al, 1986). Initiation at other prokaryotic replication origins 
appears to follow the same three step sequence as in E. coli.
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Initiation in eukaryotes.
Initiation in eukaryotic viruses is probably similar to initiation in E. coli. Certainly 
in SV40, the most studied, the same pattern occurs — binding of specific sequences by a 
protein resulting in helix melting at an adjacent site and the entry of other replication 
proteins. In these genomes the melted region is usually a palindrome or AT-rich region 
(Challberg and Kelly, 1989). The SV40 origin is contained within a 450 bp region, the 
minimal origin being 64 bp. The minimal origin contains three components: 1) four short 
repeats which bind T antigen; 2) seventeen AT base pairs which may participate in origin 
melting; and 3) a 15 bp palindrome which is the first region melted during initiation 
(Borowiec et al, 1990). T antigen opens the origin by its intrinsic helicase action. It is not 
known whether T antigen participates in loading other replication proteins into the opened 
origin but this is likely as a complex can be formed between T antigen and the host DNA 
polymerase a-primase (Smale and Tjian, 1986). Binding of transcription factors to sites 
in the origin region stimulates replication although the mechanism by which this occurs is 
uncertain (Guo etal, 1989).
In yeast, initiation begins at autonomous replication sequences (ARS) which 
confer autonomous replication on plasmids introduced into Saccharomyces cerevisiae. 
Autonomous replication sequences consist of two domains A and B both of which are 
essential. Domain A is an 11 bp sequence which is the binding site for a complex called 
the origin recognition complex (ORC), which is probably the initiator in vivo (Bell and 
Stillman, 1992; Diffley and Cocker, 1992). Domain B is a 50-100 bp AT-rich region 
adjacent to domain A, which binds an unidentified protein (Marahrens and Stillman, 1992; 
Kearsey, 1984; Umek and Kowalski, 1990). Some, but not all, autonomous replication 
sequences function as chromosomal origins in vivo, although the reasons for this are 
unknown (Linskens and Huberman, 1988).
Attempts to identify functional origins of replication in the genomes of higher 
eukaryotes have not been successful. The most promising system examined to date is 
Chinese hamster ovary (CHO) cells. CHO cells resistant to methotrexate show vast 
amplification of the dihydrofolate reductase gene region — as much as 200 kb is 
amplified up to 1000 fold. By identification of the restriction fragments which are 
replicated earliest in S phase, initiation has been localised to a 28 kb region (Leu and 
Hamlin, 1989; Anachkova and Hamlin, 1989). Initiation also appears to begin in the same 
region in non mutant cells (Burhans et al, 1990). However experiments attempting to 
localise an origin or origins of replication in this region have given conflicting results. It 
is possible that a large region, perhaps specified by packing rather than sequence, 
functions as a replication origin in vivo (Vaughn et al, 1990).
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ii) Priming.
Priming is required for all DNA replication as no DNA polymerase can begin a 
DNA chain. Priming probably evolved to contribute to high fidelity DNA replication as 
the proof reading and error correcting mechanisms of DNA polymerases may not operate 
efficiently during chain initiation. Priming by short RNAs, synthesised for the purpose by 
a specific primase, is by far the most common method of priming. Beginning chains with 
RNA allows the beginning of the chain to be recognised as prone to errors, excised, and 
the gap filled by a high fidelity DNA polymerase. Only the extreme 3’ ends of linear 
DNA cannot be copied by this mechanism. Prokaryotic priming is generally very 
different from that occurring in eukaryotes but has some aspects that are instructive.
Priming of the genomes of E. coli and its bacteriophages.
Priming of DNA replication in E. coli and many of its bacteriophages is carried 
out by the dnaG gene product, the E. coli primase (Komberg and Baker, 1991). The dnaG 
gene product is a 60 kD protein which synthesises primers of approximately 11 
nucleotides in vivo, recognising the sequence 3’-GTC (Rowen and Komberg, 1978; Kitani 
et al, 1985; Hiasa et al, 1989a). When acting alone the primase appears to recognise a 
specific stem loop structure in some bacteriophage single stranded DNA, as well as the 3'- 
GTC sequence (Lambert et al, 1986; Hiasa et al, 1989b; Sims and Benz, 1980). However 
during replication of the E. coli chromosome dnaG primase probably acts as part of a 
mobile multiprotein complex called a primosome. Two types of primosome have been 
found, the dnaG-dnaB primosome and the (|>X 174-type primosome. Other primosome 
components may induce a similar stem loop-type conformation in the chromosomal DNA.
DnaB-dnaG primosome.
On most single stranded substrates dnaG will synthesise primers only in the 
presence of E. coli dnaB protein (Arai and Komberg, 1979). The dnaB protein is a 
helicase which has associated DNA-dependent ATPase activity, and almost certainly 
melts the DNA ahead of the advancing replication fork in vivo (Matson and Kaiser- 
Rogers, 1990; LeBowitz and McMacken, 1986). To be active as a helicase dnaB requires 
a pre-formed fork in its substrate DNA. The protein moves 5 -3 ' on the strand to which it 
is bound with a speed of 35-60 bp per second. SSB, the E. coli single stranded DNA 
binding protein, stimulates the helicase activity if added after helicase binds the DNA, 
probably by keeping the separated strands apart (LeBowitz and McMacken, 1986). DnaB 
and the primase associate with the template in a distributive manner, that is dissociation 
and reassociation occur at a high rate. When the reassociation of dnaB with the template 
is limiting the rate of priming can be increased by the addition of dnaC protein which 
increases the affinity of dnaB for DNA (Arai and Komberg, 1981; Wahle et al, 1989). It
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is not clear how dnaB stimulates priming but use of non-hydrolysable ATP analogues ihas 
shown that the helicase activity is not required. While the functional interaction of dmaB 
and primase is not in doubt, a physical association between the two proteins has not been 
demonstrated. It is possible that only a weak interaction exists or that the two proteins 
interact through a DNA structure. Priming by dnaG and dnaB is completely inhibited, by 
previously added SSB (Arai and Kornberg, 1979). Despite this the dnaG-dnaB piim;ase 
perhaps provides a model for priming of the leading strand at oriC because at oriC the 
melted DNA may be kept free of SSB by the action of dnaA protein.
The (J)X 174-type primosome.
During lagging strand synthesis primase must act on SSB-coated single struided 
DNA. As the dnaB.dnaG complex is inactive on SSB-coated single stranded DNA, 
priming must occur by another mechanism under these conditions. This may invol/e the 
<|)X 174-type primosome (Arai et al, 1981). The (j)X174-type primosome is a cotip>lex 
assembly of proteins which supports multiple priming events and is insensitive to 
inhibition by SSB. It primes conversion of the single stranded form of the <|)X174 genoime 
to the double stranded form, acting at a specific site the primosome assembly site pas, a 
70 nt stretch of DNA which may form a stem loop structure (Greenbaum and Maiains,
1985). Sequences analogous to pas have been found in the E. coli chromosome bit iit is 
not known whether they function in vivo. The proteins required for primosome assembly, 
in addition to dnaB protein, primase, (and SSB bound to the template), are PriA,PriB, 
PriC, dnaC, and dnaT, all E. coli proteins. Although all of these proteins are required for 
the assembly of the primosome, it is not clear what part many of them play in assembly or 
which proteins become stably associated with the complex. The mobile primosome racks 
along single stranded DNA synthesising multiple primers. Movement may be poweed by 
either the PriA or dnaB helicase which translocate in opposite directions along a DNA 
strand (Lee and Marians, 1989). Primase is not required for either the integrity ir tthe 
mobility of the complex. In fact the preprimosome may be the real processive entity wdth 
primase cycling on and off the complex to synthesise primers.
Several features of the <|)X 174-type primosome make it an attractive mocfel for 
priming of discontinuous strand synthesis in vivo. Firstly, the primosome is male up 
entirely of E. coli replication proteins, five of which (dnaB, dnaC, dnaT, PriA atnd 
primase) have been implicated genetically in chromosomal replication, and three of vhiich 
(dnaB, dnaC, and primase) are essential for oriC plasmid replication in vitro. Sectncflly, 
the complex generally moves 5 -3 ' on the DNA strand to which it is bound i.e. itt is 
powered by dnaB protein. On replicating DNA this would place it on the discontiniouisly 
copied strand moving in the same direction as the advancing replication fork. Thirdy, tthe 
complex is processive, remaining stably associated with the template through multiple 
rounds of priming. The ability of the primosome to apparently move in both directions
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along a DNA strand suggests that it in fact loops the DNA. This would permit it to act as 
the motive force for the two halves of the DNA pol III holoenzyme dimer thought to 
operate at the replication fork, allowing them to synthesise both strands in a coordinated 
manner (Lee and Marians, 1989; Lasken and Kornberg, 1988). The <|)X174~type 
primosome is involved in the replication of the discontinuous strand of the plasmid 
pBR322 (Minden and Marians, 1985), further strengthening the suggestion that it is the 
discontinuous strand primosome during replication of the E. coli chromosome.
Gene 41 and 61 proteins of phage T4.
The products of genes 41 (gp41) and 61 (gp61) of phage T4 synthesise 
pentaribonucleotides on single stranded DNA which can be extended by the phage DNA 
polymerase (Keppel et al, 1988). Gp41 functions as a 5 -3 ' helicase in isolation but both 
gene products are required for the synthesis of primers in vivo. Gp41 does not form a 
stable complex with single stranded DNA despite its helicase activity but is stabilised on 
the DNA by gp61 protein suggesting that the proteins associate. Optimum activity of the 
two proteins occurs at a ratio of five gp41 to one gp61 (Richardson and Nossal, ]989). 
The primer recognition sequence is 3'-TTG in vivo (Keppel et al, 1988).
Gene 4 protein of bacteriophage T7.
Gene 4 protein (gp4) of bacteriophage T7 is a helicase and a primase ind is 
required for phage DNA replication (Keppel et al, 1988; Matson and Kaiser-Rogers,
1990). There are 56 kD and 63 kD forms of this protein, both of which have 5 -3 ' helicase 
activity and stimulate the T7 DNA polymerase. Only the larger of the two has primase 
activity. On reaching a specific recognition site gp4 catalyses the synthesis of tetri- and 
pentanucleotides. The consensus recognition site is 3’-CTG(G/T)(G/T). During DNA 
synthesis the helicase is highly processive while the primase shows no processivity 
indicating that more than one molecule of gene 4 protein is required at the replication fork 
(Nakai and Richardson, 1988). A heteromultimer is the most likely form with the piimase 
continually associating and dissociating as primers are synthesised. The absence of a 
primase activity from the 56 kD form of the protein may allow it to translocate on the 
leading strand without stalling at primase recognition sites. Gene 4 protein stimulates 
DNA synthesis only by T7 DNA polymerase: the primers it synthesises are extended only 
by this enzyme. The polymerase also facilitates binding of gp4 to DNA. These results 
suggest a direct interaction between the proteins in vivo. Such an interaction ha? been 
detected in vitro (Nakai and Richardson, 1986a; 1986b). The polymerase-piimase 
complex may stabilise primers on the template and speed primer recognition oy the 
polymerase.
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Comparison of prokaryote replicative helicases.
Opening of the replication fork by helicases is closely linked to priming. It is 
therefore appropriate to consider at this point prokaryotic helicases involved in 
replication. The E. coli dnaB protein, bacteriophage T7 gp4 protein, and bacteriophage 
T4 gp41 protein form a family of replicative helicases with similar properties in 
unwinding duplex DNA and in complex formation at the replication fork. All three 
proteins unwind DNA processively, moving with 5'-3f polarity. At a replication fork this 
would place them on the discontinuous strand moving in the same direction as the 
advancing fork. Melting of a duplex by these enzymes requires a pre-formed fork 
suggesting that the helicases bind both strands of DNA as they advance. These helicase 
proteins also stimulate primer synthesis. In contrast, the properties of PriA protein are 
quite distinct in terms of polarity of movement, processivity, and response to DNA 
polymerase, suggesting a different role for this protein in replication. The properties of 
the helicases are summarised below .
Table 4. Comparison of E. coli and phage replicative helicases (see Matson and Kaiser- 
Rogers, 1990).
Protein Mass Polarity Rate Processivity Effect of Effect of
(kD), (bp/s) primases DNA
form polymerase
dnaB 50 5-3 ' 35-60 higha stimulated stimulates
hexamer 750a >50kb by E. coli 
dnaG.
rolling-circle
synthesis.
T7gp4 63, 56 
multimer
5 -3 ’ 300a higha same
protein.
specific for 
T7 pol.
T4 gp41 59
multimer
5-3 ' 250a higha stimulated 
by T4
gp61.
accessory
proteins
stimulate.
PriA 76
monomer
3—5' 50 <500bp none none
a When DNA polymerase is present.
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Priming of DNA replication in eukaryotes.
Eukaryotic a  DNA polymerases, which are involved in chromosomal replication, 
also have primase activity (Lehman and Kaguni, 1989). Pol a  purified from numerous 
sources, including human cells and yeast, is composed of four subunits of 180,70, 6D, and 
50 kD. Primase activity is detected in preparations of the 60 and 50 kD subunits (Kaguni 
et al, 1983). These proteins sediment as a heterodimer and are immunoprecipitated by an 
antibody reacting with the smaller protein. Neither protein is active alone and the active 
site of the enzyme appears to be made up of sequences from each subunit (Foiani et al, 
1989). The genes encoding the two subunits are both essential in yeast (Lucchini et al, 
1987; Lehman and Kaguni, 1989).
When DNA synthesis is proceeding, the Drosophila primase makes primers of 12- 
14 nt and the yeast and mouse enzymes primers of 8-12 nt (Conaway and Lehman, 1982; 
Tseng and Ahlem, 1983; Singh etal, 1986). Primers are initiated with a purine, however 
beyond this little if any sequence preference is apparent in the placing of primers. Thus 
eukaryotic primases appear to copy a certain length rather than reading a particular 
sequence as prokaryotic primases do. Deoxyribonucleotides rather than ribonucleotides 
can be incorporated in all but the first position of the primer and the exact composition of 
primers is influenced by the composition of the nucleotide triphosphate pools (Komberg 
and Baker, 1991). The fidelity of copying, at least for Drosophila and calf thymus 
primases, is low (Zhang and Grosse, 1990; Cotterill et al, 1987a).
If the primase subunits are assayed in the absence of polymerase, multiples of the 
characteristic primer length are produced (i.e. 24-mers and 36-mers) (Cotterill et al, 
1987a; Brooks and Dumas, 1989). Also primer synthesis is blocked after an initial burst. 
No multiple length primers are produced in the presence of an active DNA polymerase 
subunit. These results suggest that the polymerase and primase activities of the complex 
are coordinated although it is not known how the primer terminus is moved from the 
primase to the polymerase active site.
The close coupling of helicase and primase activities in prokaryotic replication 
suggests that the same coupling might occur in eukaryotes. However very little is known 
about replicative helicases in eukaryotes and in these organisms primase is more usually 
coupled to DNA polymerase as described above. SV40 virus T antigen is a helicaje and 
can associate directly with DNA polymerase a-primase but whether this interaction is 
required for priming of SV40 DNA replication is unknown (Smale and Tjian, ]986). 
Apart from the SV40 system, the HSV-1 UL5/UL8/UL52 assembly is the only known 
eukaryotic primase with an associated helicase activity.
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The elongation of DNA chains is carried out by template-directed DNA 
polymerases. A number of DNA polymerase have been found in all organisms examined 
and they all have the same basic properties. E. coli contains three DNA polymerases (I, 
II, and III) and other prokaryotes have analogous enzymes. Eukaryotes contain five DNA 
polymerases a , p, y, 8 and e. E. coli DNA polymerase I is understood in more detail than 
the other polymerases and is the only DNA polymerase whose structure has been 
determined. Many of its properties are common to all DNA polymerases. E. coli pol II is 
primarily a repair enzyme, active in DNA damage-induced (SOS) repair (Campbell et al, 
1972; Bonner et al, 1988). Description of its properties is limited therefore to table 5, 
which summarises the properties of the E. coli DNA polymerases.
E. coli DNA polymerase I
E. coli DNA polymerase I is a 103 kD protein (928 amino acid residues) 
(Kornberg et al, 1956; Jovin et al, 1969; Joyce et al, 1982). It is a globular molecule with 
a diameter of 65 A and can therefore contact approximately 2 turns (20 bp, c.70 A) of 
helical DNA (Joyce and Steitz, 1987). Three activities are present in the intact protein: 
template-directed nucleotide polymerisation; proof-reading 3 -5 ' exonuclease; and 5 -3 '
Table 5. The DNA polymerases of E. coli. Data from Komberg and Baker, 1991.
pol I pol II pol HI (core)
Polymerisation: 5'-3' + + +
Exonuclease: 3'—5' + + +
Exonuclease: 5'—3' + - -
Stimulation by (5 - + +
Size (kD) 103 90 130, 27.5, 10
Molecules / cell 400 ? 10-20
Turnover number51 600 30 9000
Structural genes polA polB dnaE or polC0
a Number of nucleotides polymerised per minute per molecule at 37 °C. 
b Gene for a  subunit.
exonuclease. The protein is easily separated into two fragments by proteases, the small N 
terminal portion (35 kD) containing the 5 -3 ' exonuclease activity and the large C terminal
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portion (68 kD) containing the polymerisation and 3 -5 ' exonuclease activities (Setlow et 
al, 1972). Inhibitors or point mutations can inactivate the 5 -3 ' exonuclease, the 3 -5 ' 
exonuclease, or the polymerase and leave the other activities intact, showing that each is 
in an independent domain of the protein (Derbyshire et al, 1988; Lehman and Uyemura,
1976).
The structure of the large fragment of DNA polymerase I has been determined by 
X-ray crystallography (Ollis et al, 1985; Freemont et al, 1988). The structure obtained at 
2.75 A resolution shows the fragment folded into two domains: a large domain (residues 
521-928 of the intact protein) and a small domain (residues 324-517 of the intact 
protein). The large domain contains a cleft, 20-24 A wide and 25-35 A deep, with sides 
made up of many a  helices and a base of P sheets. Eight base pairs of B form DNA can 
fit into the cleft and numerous studies have demonstrated that the cleft is the site of DNA 
binding (Freemont et al, 1988; Kornberg and Baker, 1991). Electrostatic field 
calculations for the large fragment also show that the greatest positive potential is located 
appropriately within the cleft (Warwicker et al, 1985). The a  helices in the cleft may 
provide threads that direct one groove of the DNA along a spiral path so that the 3' 
terminus of the growing strand remains in the active site. A representation of the crystal 
structure of DNA polymerase I may be found in Joyce and Steitz (1987).
The polymerisation activity of DNA pol I operates on the 3'-OH of a primer DNA 
or RNA annealed antiparallel to a template strand. Pol I is tolerant of a number of 
template structures, accepting short or long 5' overhangs of the template strand, or duplex 
DNA with short single stranded gaps. Sedimentation and electron microscope studies 
with model templates have revealed the polymerase's preferences for binding (Englund et 
al, 1969; Griffith et al, 1971). The polymerase binds to the 3'-OH of single strand-double 
strand junctions and at the end of duplexes, but never in the centre of fully duplex 
molecules. Single stranded DNA is also bound as are nicks in double stranded DNA. 
DNA pol I has low processivity; only 20 nucleotides are added to the primer per binding 
event (Matson and Bambara, 1981). In addition to acting at conventional primer termini, 
DNA pol I is one of the few DNA polymerases able to initiate polymerisation at a nick in 
an otherwise fully duplex DNA unaided by any other factors (Lundquist and Olivera, 
1982). This process involves helix melting and displacement of the 5' end of the chain. 
Coupled with the 5'-3' exonuclease activity, the polymerising activity results in nick 
translation and is exactly that required to remove primers and complete Okazaki 
fragments during DNA replication.
The proof-reading 3-5 ' exonuclease activity of DNA pol I cleaves a mismatched 
terminus and is vital to the fidelity of the enzyme (Brutlag and Komberg, 1972; Kunkel, 
1988). The exonuclease works preferentially on a frayed end of double stranded DNA. 
The active site is contained in the small domain of the Klenow fragment of the 
polymerase as revealed by the presence of an inhibiting nucleotide monophosphate and
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certain divalent metal ions, in the crystal structure. Mutation of the appropriate amino 
acid residues prevents metal binding and also destroys proof-reading exonuclease activity 
(Derbyshire etal, 1988; 1991). Mutations which destroy the proof-reading activity have a 
strong mutator phenotype.
The primary phenotypes of E. coli with mutations in polA, the DNA polymerase I 
gene, are delayed joining of nascent DNA fragments and an inability to repair damaged 
DNA. These defects are due to the impaired gap-filling and excision functions of the 
enzyme. Delayed joining of nascent DNA fragments during replication is due to the 
failure to remove RNA primers and strongly suggests that this process is performed in 
vivo by pol I (Komberg and Baker, 1991).
E. coli DNA polymerase i n  holoenzyme.
E. coli DNA polymerase in  holoenzyme is the principo\ replicative enzyme of E. 
coli (Gefter et al, 1971; Wickner et al, 1973). Each cell contains approximately 10 
holoenzyme complexes. The holoenzyme contains 10 different subunits (a, e, 0, x, y,
5', %, \|/, and (3) and has a molar mass of >900 kD (Maki et al, 1988). It dissociates easily 
on extraction from cells into a number of sub-assemblies, the smallest of which is the 
core. Reconstitution of holoenzyme on SSB coated single stranded DNA leads to a rate of 
DNA synthesis of 700 nt per second at 37 °C (Mok and Marians, 1987). This is close to 
the rate of 1000 nt per second observed in vivo. The holoenzyme also has a processivity 
of greater than 105 (Mok and Marians, 1987).
The catalytic core of the holoenzyme, which cannot be dissociated without 
denaturing the constituent proteins, comprises the proteins a , e, and 0 (Maki and 
Kornberg, 1985; 1987). Subunit a  contains the polymerase active site while the 3 -5 1 
exonuclease is contained within the e subunit, mutation of which leads to a 105-fold 
increase in cell mutations (Scheuermann and Echols, 1984; Ehrlich and Cox, 1980). The 
role of the 0 subunit is unknown, as its absence does not alter the polymerase or 
exonuclease activities. A structural role may perhaps be inferred.
Accessory subunits of the holoenzyme.
The accessory subunits of the holoenzyme are x, the y  complex (y, 6, 6', %, \|/), and 
p. The x accessory factor plus the core forms the pol in ' subassembly of the holoenzyme. 
Pol HI1 can be isolated in the form core2X2 (McHenry, 1982) and this dimer is also present 
in higher assemblies (Maki et al, 1988). x is a single stranded DNA dependent ATPase 
and increases the processivity of the core about six-fold (Lee and Walker, 1987).
The y  complex was originally identified as a factor needed with the core and the p 
subunit to reconstitute the high processivity of the holoenzyme (McHenry and Komberg,
1977). Judging from its molar mass the complex contains 2 copies each of proteins y, 8,
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5', and \\f. The complex is active in reconstituting high processivity at a level of ten 
core and (3 subunits to one y  complex, suggesting that the y  complex has a catalytic role 
(Maki and Kornberg, 1988a). The functions of the individual subunits are unknown.
The (3 component is the holoenzyme's most important processivity factor 
(Johanson et al, 1986; Lasken and Kornberg, 1987). It is a dimer of 40.6 kD subunits, p 
dissociates readily from the other nine proteins of the holoenzyme in the absence of ATP 
but is firmly bound in its presence, p is not demonstrably a DNA-binding protein but 
becomes attached to circular DNA duplexes in the presence of the y  complex and ATP. 
Scission of the DNA releases p (Stukenberg et al, 1991). These results have been 
explained now that the structure of p has been determined by X-ray diffraction (Kong et 
al, 1992). This has revealed that the protein dimer is a ring, with a hole in the centre large 
enough to accommodate a B form DNA helix suggesting that P closes around duplex 
DNA. The central hole is lined by alpha helices with their long axes perpendicular to the 
grooves of the B form helix which should allow p to slide easily on duplex DNA.
Holoenzyme dynamics.
DNA pol III holoenzyme can be reconstituted from its core, the P subunit, the y  
complex and ATP. A pre-initiation complex is formed when the y  complex causes p to 
bind to the template-primer using ATP as an energy source (Burgers and Kornberg, 
1982a; 1982b; O'Donnell, 1987; Maki and Komberg, 1988b). Binding presumably 
involves opening the ring formed by p and closing it around the DNA. The reaction is 
slow, taking 1-2 minutes, and the action of the y  complex is catalytic. Within a few 
seconds the pre-initiation complex binds a core, with or without x, forming an initiation 
complex in which the y complex is present in sub-stoichiometric amounts. With x, 
formation of the initiation complex is more rapid, the complex is more stable, and the 
processivity of the elongation complex is greater — similar to that of the holoenzyme. 
With x present the enzyme does not pause at secondary structures in the template or at 
annealed strands, consistent with the helicase activity of x. Elongation complexes isolated 
by incubating the reconstituted enzyme with only three dNTPs have a similar composition 
to initiation complexes. Dissociation of the holoenzyme from a completed duplex takes 
several minutes. However the enzyme is able to traverse a duplex region of 15 bp (in the 
direction of elongation) to reach the terminus of a new primer in less than a second 
(ODonnell and Komberg, 1985). The core can move from one pre-initiation complex to 
another. This movement is very rapid, taking about ten seconds, and may reflect recycling 
of the holoenzyme on the lagging strand in vivo (O'Donnell, 1987).
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With a molar mass near 900 kD, pol III holoenzyme probably contains two p 
dimers and two of each of its other subunits (Maki et al, 1988; Johanson and McHenry,
1984). The holoenzyme is thought to be an asymmetric dimer of the form (core-p2- 
x2) (core- p2-y complex) possibly joined through 0. A x dimer on one half of the complex 
would increase processivity to allow copying of the leading strand of the template, while a 
y complex attached to the other half would allow repeated recycling of the polymerase on 
the lagging strand. Both the structure and the dynamics of the holoenzyme in vitro 
support this conjecture (Maki et al, 1988; Johanson and McHenry, 1984).
Comparison with other systems suggests that the holoenzyme is likely to interact
with other proteins at the replication fork although such interactions have not been
detected. For example bacteriophage T7 DNA polymerase is coupled to the phage
helicase and primase during DNA replication and mammalian polymerase a  is closely
w it h
linked to primase (see later). Polymerases from a number of organisms also interactive 
organisms single stranded DNA-binding proteins — for example T4 bacteriophage 
(Huberman et al, 1971).
T4 DNA polymerase.
The proteins constituting T4 bacteriophage DNA polymerase are the products of 
genes 43, 44, 45, and 62 (Marians, 1992; Morris et al, 1975). The product of gene 43 
(gp43) is the catalytic subunit and is homologous to the eukaryotic a  DNA polymerase 
family. Operating alone gp43 can copy only primed single strands, not nicked duplexes, 
but its turnover rate of 400 nucleotides per second is similar to the rate of replication fork 
movement in vivo (Huang et al, 1981; Mace and Alberts, 1984). The three polymerase 
accessory proteins gp44, gp45, and gp62, complex with gp43 and stimulate it forty-fold 
when the T4 single stranded DNA binding protein is also present. This enzyme system is 
able to replicate through any secondary structure and has high processivity — more than 
20,000 nucleotides are added per binding event. Formation of the processive complex is 
similar to the analogous process in E. coli in that hydrolysis of ATP to ADP is requited. 
Once the complex is bound, a non-hydrolysable ATP analogue can support elongation. 
The presence of the T4 helicase stimulates the rate of movement of the 'holoenzyme' 
complex by a factor of three (Cha and Alberts, 1988).
The DNA polymerase has a very active 3 -5 ' exonuclease which gives the enzyme 
a high fidelity (Sinha, 1987; Bessman etal, 1974). There is no apparent 5 -3 ' exonuclease 
but sequences similar to those in the 5-3 ' exonuclease domain of E. coli pol I are found in 
the N-terminus of the protein (Reha-Krantz, 1990).
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T7 DNA polymerase.
T7 DNA polymerase is a 1:1 complex between the phage gene 5 protein (gp5) and 
the host thioredoxin (Tabor etal, 1987; Modrich and Richardson, 1975). In addition to its 
polymerising activity gp5 has a 3'-5' proof-reading exonuclease activity (Hori et al, 1979; 
Adler and Modrich, 1979). A 5-3* exonuclease is encoded by phage gene 6 (Kerr and 
Sadowski, 1972a; 1972b). Gp5 alone has a maximum processivity of 50 nucleotides but 
this is increased 1000-fold by the thioredoxin (Tabor eta l, 1987). Thioredoxin increases 
processivity by binding to gp5, stabilising the gp5-primer-template complex 20-80 fold 
(Huber et al, 1987). The action of the polymerase is coordinated to the phage 
helicase/primase by a direct interaction between the proteins. The polymerase also 
interacts with the gene 6 protein (Nakai and Richardson, 1986a; 1986b).
DNA polymerases of eukaryotes
Five DNA polymerases have been detected in mammalian cells of which four (a, 
p, 6, and e) are nuclear and one (y) is mitochondrial, a  and 8 are required for replication, 
p is involved in repair and the function of e is unclear, y is responsible for replicating the 
mitochondrial chromosome. Only a , 8 and e will be described here. Studies of the 
polymerases of the yeast S. cerevisiae have provided important insights into mammalian 
polymerases due to the availability of yeast mutants. The yeast polymerases I, II, and III 
are analogous to the mammalian polymerases a , e, and 8 respectively. The properties of 
eukaryotic polymerases are summarised in table 6 (overleaf).
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a  5 e
Yeast designation poll p o lin  po lll
Yeast gene POL1 (CDC17) POL3 (CDC2) POL2
Mass (kD)
Native >250 170 256
Catalytic core 165-180 125 215
Other subunits 70,50,60 48 55
Associated functions 
3 -5 ' exonuclease yesb yes yes
Primase yes no no
Properties
Preferred template gap polydA. oligodT polydA. oligodT
Processivity low high0 high
Fidelity high high high
Replication yes yes uncertain
Repair no uncertain uncertain
a Data from Lehman and Kaguni, 1989; So and Downey, 1988; Burgers, 1989; Bambara 
and lessee, 1991.
b Only detected with Drosophila polymerase a.
0 In the presence of proliferating cell nuclear antigen (PCNA).
DNA Polymerase a .
This enzyme is a complex of four proteins: a polymerising subunit of 165-180 kD; 
subunits of 60 and 50 kD with primase activity; and a 70 kD subunit of unknown function 
(for a review see Lehman and Kaguni, 1989). Polymerase a  is essential for chromosome 
replication as conditional lethal mutants of yeast and of mouse cells in culture are unable 
to replicate DNA at the non-permissive temperature (Murakami et al, 1985; Johnson et al,
1985). Also depletion of cell extracts with anti-pol a  antibodies prevents replication 
(Murakami et al, 1986). In addition the level of pol a  in proliferating cells changes 
according to the stage of the division cycle the cells are in (Bertazzoni et al, 1976; Craig 
et al, 1975). The relatively low processivity of pol a  and its associated primase activity 
make it an attractive candidate for the replicator of the discontinuously synthesised strand 
in vivo.
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The C-terminal portions of eukaryotic a  polymerases contain six regions of highly 
homologous sequence (I-VI) whose order has also been conserved (Larder et al, 1987; 
Wong et al, 1988; Wang et al, 1989). These regions of homology are found in other DNA 
polymerases: yeast 8 and e polymerases; human polymerase 5; adenovirus, vaccinia virus, 
and herpesvirus polymerases; and the polymerases of bacteriophages T4, <|)29 and PRD1. 
Analysis of drug resistant mutants of HSV-1 has predicted that regions I, II, and HI of the 
polymerases are involved in substrate binding and nucleotide polymerisation (see HSV 
DNA replication section). The N-terminal portions of the a  polymerases contain three 
regions with homology to the 3 -5 ' exonuclease domains of bacteriophage T4 and <|)29 
DNA polymerases (Spicer etal, 1988; Bemad etal, 1989). However exonuclease activity 
is detectable only in preparations of Drosophila DNA polymerase a  and this only on 
removal of the 70 kD subunit (Cotterill et al, 1987b). An exonuclease has been detected 
complexed to human DNA polymerase a  (Skames et al, 1986).
DNA polymerase a  operates by an ordered mechanism binding sequentially to the 
single stranded template, the primer, and finally to the complementary dNTP (Wong et al,
1986). The activity of the enzyme is dependent on pH  and Mg2+ concentration, pH  7.0 
and 5mM Mg2+ being optimum. The processivity of the enzyme varies from 2 to 2000 
nucleotides polymerised per association, rising with a decrease in temperature, pH, or 
Mg2+ concentration (Tan et al, 1987). Accessory factors may enhance the processivity in 
vivo. Fidelity is very high, at least for the Drosophila enzyme, with as few as one error 
per 106 nucleotides incorporated (Cotterill et al, 1987b).
A number of proteins that stimulate polymerase a  have been identified. Protein A 
(also known as RF-A or RP-A) is a single stranded DNA binding protein that stimulates 
polymerase a  during the replication of the SV40 chromosome in vitro (Ishimi et al, 1988). 
It has three subunits of 70,32, and 13 kD and may assist the helicase activity of T antigen. 
Replication factor C (RF-C or RP-C) is a multimeric factor required for SV40 DNA 
replication. RF-C is a DNA-dependent ATPase and facilitates binding of polymerase a  to 
the primer terminus (Tsurimoto and Stillman, 1989; 1990). Another distinct a-accessory 
factor (AAF), isolated from cultured mouse cells, contains proteins of 132 and 45 kD 
(Goulian et al, 1990; Goulian and Heard, 1990). It stimulates self-primed synthesis by 
polymerase a  on single stranded DNA and increases the affinity of the enzyme for 
primers, raising processivity ten-fold so that the polymerase produces newly synthesised 
DNA the size of mammalian Okazaki fragments. Polymerase a  has also been isolated as 
part of a large complex containing a diadenosine-tetraphosphate (A(p4)A)-binding protein, 
a 3 -5 ' and 5 -3 ' exonuclease, and primer recognition proteins which stimulate the rate of 
primer usage (Vishwanatha et al, 1986; Skarnes et al, 1986).
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DNA polymerase 8
DNA polymerase 5 was discovered as a new type of DNA polymerase which at 
the time was unique among mammalian DNA polymerases in possessing an intrinsic 3 -5 ' 
exonuclease activity (Byrnes et al, 1976; for reviews see Burgers, 1989; Bambara and 
lessee, 1991). The human enzyme consists of two proteins with molar masses of 125 and 
48 kD, the larger being the catalytic subunit (Lee et al, 1991). The gene for human pol 8 
has been isolated and sequenced (Yang et al, 1992). Polymerase 8 plays a critical role in 
DNA replication as shown by the following evidence: (1) Studies in permeabilised cell 
systems have implied that pol 8 is involved in replication and repair (Hammond et al, 
1987; Dresler and Kimbro, 1987). (2) A 36 kD protein identified as a processivity factor 
for pol 8 was shown to be proliferating cell nuclear antigen (PCNA) or cyclin, a protein 
whose expression is strongly tied to the S phase of the cell cycle (Tan et al, 1986; Bravo 
et al, 1987; Prelich et al, 1987b). (3) Pol 8 and PCNA are necessary for replication of the 
SV40 chromosome in vitro (Prelich et al, 1987a; Lee et al, 1989). (4) The gene for the 
yeast protein equivalent to pol 8 (pol III) is CDC2, a critical cell division cycle gene 
(Boulet etal, 1989; Sitney etal, 1989).
PCNA is a key accessory factor for pol 8 raising its processivity forty fold, thus 
enabling it to replicate a singly primed phage DNA circle (Tan et al, 1986; Bravo et al, 
1987; Bauer and Burgers, 1988). It is a dimer of 37 kD subunits that has no enzymatic 
activity of its own and does not bind single or double stranded DNA. However mixing of 
PCNA with pol 8 increases the affinity of the enzyme for primed DNA. Two other 
proteins are needed, along with PCNA, for pol 8 action during replication of the SV40 
chromosome. These are replication factor A (RF-A) (Kenny et al, 1989), and RF-C, 
which binds the primer terminus. Isolated pol 8 is very active on poly dA.oligo dT but 
only weakly active on DNA of high sequence complexity. However reconstitution of a 
complex of pol 8 with PCNA, RF-A, RF-C, and ATP does support replication of complex 
DNA at the physiological rate of greater than 100 nucleotides per second (Tsurimoto and 
Stillman, 1990; Tsurimoto etal, 1990; Lee and Hurwitz, 1990).
DNA polymerase e
DNA polymerase e was initially thought to be a form of pol 8 due to their many 
shared properties. These are: an overt 3 —5' exonuclease activity; lack of primase activity; 
preference for poly dA.oligo dT as a template; and high processivity (Bambara and lessee,
1991). The two enzymes also cross-react immunologically (Wong et al, 1989). The yeast 
gene for pol 8 and that thought to encode pol e are nevertheless distinct (Yang et al,
1992). Despite this, determination of the relationship between mammalian polymenses 8 
and e must await the isolation of the mammalian pol e gene. Human pol 8 has a molar 
mass of 215 kD and the yeast equivalent a predicted molar mass of 256 kD (Syvaoja and 
Linn, 1989; Morrison et al, 1990). The clearest distinction between polymerases Sand e
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is the high processivity of e in the absence of PCNA on the preferred poly dA.oligo dT 
template (Syvaoja and Linn, 1989; Syvaoja et al, 1990; Lee et al, 1991). A function for 
pol e in replication or repair in vivo has not been established. Pol e (but not pol a) is able 
to restore DNA repair synthesis to permeabilised UV-irradiated HeLa cells and the 
enzyme may therefore function as a repair enzyme in vivo (Nishida et al, 1988). However 
a role for pol e in replication has not been ruled out.
iv) Completion of replication.
With the original DNA strands completely copied, the new DNA fragments must 
be joined and the daughter duplexes separated for replication to be complete. These two 
steps are carried out by DNA ligase and DNA topoisomerase respectively.
DNA ligases.
DNA ligases join the 3'-hydroxyl of a nucleotide chain to a 5'-nucleotide 
phosphate juxtaposed to it during all processes involving cleavage and joining of DNA i.e. 
replication, repair, and recombination (Lehman, 1974). E. coli and bacteriophage T4 each 
produce one ligase while two types (I and II) are found in eukaryotes of which the first is 
the replicative enzyme. Ligases catalyse the coupling of their cofactor (NAD+ or ATP) to 
the 5'-phosphate of one nucleotide via a phosphate-phosphate bond. The cofactor is then 
displaced by the 3-hydroxyl of the other nucleotide as it forms the phosphodiester bond. 
A DNA ligase is encoded by vaccinia virus and shows 30% amino acid homology to the 
S. cerevisiae and S. pombe ligases (Smith et al, 1989). No DNA ligase gene has been 
found in the genomes of the herpesviruses.
DNA topoisomerases.
DNA topoisomerases interconvert topological isomers of DNA by cleaving and 
rejoining the phosphodiester backbone of the molecule. The number of superhelical turns 
present in the DNA may be altered, linked rings may be decatenated, and knots may be 
removed. There are two types of topoisomerases: type I enzymes make single stranded 
breaks in DNA and do not require an energy source; type II enzymes make double 
stranded breaks using ATP. Both types are required during replication. Either can 
provide a swivel ahead of the advancing replication fork preventing overwinding of the 
DNA, and type II enzymes can decatenate daughter molecules. Topoisomerases are also 
involved in transcription and recombination (Wang, 1985).
In E. coli, gyrase (a type n  enzyme also known as topoisomerase II) is the main 
replicative topoisomerase providing a swivel for the replication fork and decatenating 
duplexes. The type I enzymes topoisomerase I and III are also involved in replication 
(Wang, 1985).
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Two topoisomerases (I and II) are found in yeast and these are type I and II 
enzymes respectively. Either can function as the swivel at the replication fork but only 
the type n  enzyme can decatenate daughter molecules (Brill eta l, 1987; Holm eta l, 1985; 
Uemura and Yanagida, 1986). A similar result has been found in cell extracts replicating 
the SV40 chromosome in vitro (Yang et al, 1987). Vaccinia virus encodes a type I 
topoisomerase whose function is unknown (Shuman and Moss, 1987).
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IV) HSV DNA REPLICATION.
Due to the complexity of the HSV-1 genome the overall mechanism of viral DNA 
replication has not been determined. The structure of replicating viral DNA has been 
analysed by velocity gradient sedimentation, electron microscopy, and by use of 
restriction enzymes.
Sedimentation studies and restriction enzyme analysis suggest that parental DNA 
loses its free ends very soon after infection, probably becoming circular (Davison and 
Wilkie, 1983; Poffenberger and Roizman, 1985; Jacob and Roizman, 1977; Jacob e ta l, 
1979; Marks and Spector, 1988; Mocarski and Roizman, 1982b). This seems to occur by 
direct ligation of the ends. Fusion of the ends is rapid and does not require new protein 
synthesis which suggests that ligation can be carried by a cellular enzyme or a viral 
enzyme brought into the cell during infection (Poffenberger and Roizman, 1985).
Sedimentation of newly replicated viral DNA shows that it is larger than unit 
length and subsequently matures into virion DNA (Hirsch etal, 1976; 1977; Ben-Porat et 
al, 1976; Ben-Porat and Tokazewski, 1977). Electron microscopy revealed that 
replicating viral DNA is comprised of a variety of complex structures, many of which are 
greater than unit size (Jacob and Roizman, 1977; Ben-Porat and Tokazewski, 1977; Ben- 
Porat and Rixon, 1979). These include forked molecules, rings, linear molecules with 
terminal or internal loops and very large tangles. Restriction enzyme analysis 
demonstrated that in common with parental DNA, new viral genomes lack termini (Jacob 
et al, 1979; Jongeneel and Bachenheimer, 1981). Available data suggests that replication 
produces head to tail concatamers of genomes although how these are related to the 
circular parental molecules is not clear.
i) Initiation. 
The origins of replication.
In common with other genomes, HSV-1 DNA is replicated from specific origins of 
replication. The position of origins of DNA replication in the HSV-1 genome was first 
suggested by the DNA sequences contained in defective interfering particles. These are 
found after repeated passage of undiluted virus stock and contain either sequences from 
the S component or sequences from the middle of U l plus the L-S junction (Bronson et al, 
1973; Schroder et al, 1975; Frenkel et al, 1976; Locker et al, 1982). The origin sequences 
(named oris and ool) were localised more precisely and cloned into plasmids which were 
found to replicate autonomously on transfection into cells infected with HSV-1 (Stow, 
1982; Mocarski and Roizman, 1982a; Stow and McMonagle, 1983; Spaete and Frenkel, 
1982). Oris is located in the Rs region of the genome and is therefore present in two
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copies; oriL is located near the centre of U l, between genes Ul29 and Ul30. The 
locations of oris and or^  are shown in figure 1. L-S junction sequences are invariably 
found in defective interfering particles because they contain the a sequence which is 
required for cleavage and packaging of viral DNA.
Table 7. The HSV-1 DNA replication proteins.
Gene Estimated Mr from SDS 
gels
Function
UL5
UL8
UL9
UL29 (ICP8) 
UL30 (pol) 
UL42 
UL52
99.000
70.000
85.000
130.000
140.000
65.000
114.000
helicase/primase 
helicase/primase 
origin binding 
ssDNA binding 
catalytic subunit of pol 
pol processivity factor 
helicase/primase
The ability of oris-containing plasmids to replicate transiently in cells infected 
with HSV-1 was used to develop an assay to uncover the viral genes required for origin- 
dependent DNA replication (Challberg, 1986; Wu et al, 1988; McGeoch et al, 1988b). 
Fragments of the viral genome produced by restriction enzyme digestion were transfected 
into cells along with the origin-containing plasmid and shown to support its replication. 
Subcloning of each fragment, together with DNA sequence analysis, identified 7 genes 
that were necessary and sufficient for the amplification of origin-containing plasmids. 
These included the genes for the viral DNA polymerase (UL30), the major DNA-binding 
protein ICP8 (UL29), and the 65 kD DNA-binding protein (UL42), all of which had been 
previously identified. The remaining 4 genes UL5, UL8, UL9, and UL52 had not been 
characterised previously. The positions of these genes in the viral genome correspond 
closely to the mapped mutations of DNA" mutants falling into 7 complementation groups 
(Purifoy etal, 1977; Chartrand etal, 1980; Coen etal, 1984; Conley etal, 1981; Weller et 
al, 1987; Carmichael et al, 1988; Goldstein and Weller, 1988a; Marchetti et al, 1988; 
Carmichael and Weller, 1989; reviewed by Weller, 1990). This close concordance of 
results suggests that the products of the 7 genes identified are genuinely involved in DNA 
replication. The plasmid amplification assay has recently been shown to function in insect 
cells infected with baculoviruses overexpressing the 7 replication proteins (Stow, 1992). 
This system provides a convenient method by which mutated replication proteins can be 
screened for activity and produced in amounts sufficient for biochemical studies. It also
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indicates that any host cell functions required for HSV-1 DNA replication are conserved 
between mammalian cells and insect cells.
The sequences of oris and oh l CQptain similar regions. (The structure of oris is 
shown in figure 5.) In particular both origins contain an extensive palindrome of which 
the central 18 base pairs are solely AT residues (Murchie and McGeoch, 1982; Quinn and 
McGeoch, 1985; Knopf et a l, 1986). The oriL palindrome is much larger than that in oris 
(144 and 46 residues respectively), and cloned oriL is unstable in E. coli for this reason 
(Weller et a l,  1985). Due to this instability most analyses have been performed on oris- 
The minimum sequence required for oris function is similar to sequences contained within 
the oriiL palindrome suggesting that the two types of origin may be equivalent. It is not 
clear why HSV-1 possesses three origins of replication. Mutants viruses lacking oriL or 
one cotpy of oris have been isolated and have no apparent growth defect either in cultured 
cells o<r in animal models (Longnecker and Roizman, 1986; Polvino-Bodnar et a l, 1987). 
A virus lacking oriL and containing two partially defective copies of oris has been isolated 
and has a significant growth defect compared to an analogous virus containing a wild type 
oriL (Challberg, 1991). These data strongly suggest that oris and oriL function 
in the context of the viral genome.
BOX III BOX I BOX II
AAAGAAGTGAGAACGCGAAGCGITCGCACTTCGTCCCA(AT)6TATTAGGGCGAAGTGCGAGCACTGG
Figure 5. The structure of oris. Oris is shown as it would appear in the internal long 
repeat in the prototype orientation of the genome. Boxes I, n, and IE are shown with the 
origin palindrome.
Analysis of oris suggests that it consists of two parts: a core origin, and flanking 
regions that enhance replication by methods not yet established (Lockshon and Galloway, 
1988; Deb and Doelberg, 1988; Weir and Stow, 1990; Hernandez et a l, 1991; Wong and 
Schaffer, 1991). The core origin probably consists of 4 domains: three regions named box 
or site I, II and III, and the central AT-rich region (see figure 5). Boxes I and E, and the 
AT-rich region have been shown by genetic approaches to be essential for function in 
vitro (Lockshon and Galloway, 1988; Weir and Stow, 1990; Hernandez et a l,  1991). 
Boxes I and II (each 11 base pairs) bind the origin-binding protein (UL9 gene product) 
with high affinity. Box III is also a binding site but has much reduced affinity, despite 
differing from the box I sequence at only one position (Koff and Tegtmeyer, 1988; Olivo 
et al, 1988; Elias et al, 1990; Dabrowski and Schaffer, 1991). Mutations in boxes I or II 
that prevent UL9 binding also destroy or greatly inhibit origin function in vitro.
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Mutations in box III reduce replication efficiency 5-fold. Inspection in the electron 
microscope of UL9 bound to DNA molecules containing the origin sequences suggests 
that UL9 covers approximately 110 nucleotides of the DNA (Rabkin and Hanlon, 1991), a 
region much larger than the 11 base pairs protected in nuclease footprinting assays. 
However the number of UL9 molecules bound to the DNA seen in the electron 
microscope could not be determined and it is possible that the central 11 base pairs of 
each binding site are complexed in a way that protects them from nuclease attack while a 
larger portion of the DNA is in less direct contact with the origin-binding protein. The 
origin-binding protein also appears to shorten the DNA by 20-30 nucleotides and 
introduce a bend into the molecule. This may reflect wrapping of the DNA around the 
protein.
The origin binding protein UL9.
The UL9 gene product was identified as the origin-binding protein by using 
immunoprecipitation and gel retardation assays (Olivo et al, 1988; Weir et al, 1989). 
Origin-containing DNA sequences bound to the origin-binding protein were specifically 
precipitated by antibodies against UL9 protein but not antibodies against other replication 
proteins. The number of molecules of UL9 that binds to each box in the origin has not 
been established. The observation that each box contains the inverted repeat GT(G or 
T)CG suggests the possibility that UL9 binds as a symmetrical dimer to each site although 
this is by no means certain (Koff and Tegtmeyer, 1988). It is known that UL9 is a dimer 
in solution with a dissociation constant of less than 10-10 M (Bruckner et al, 1991; Fierer 
and Challberg, 1992). The origin-binding function has been localised to the C-terminal 
third of UL9, amino acids 534-851 (Weir et al, 1989). The binding of the whole molecule 
to sites I and II is cooperative, cooperativity being ascribed to the N-terminal portion of 
the molecule (Elias et al, 1990; 1992). The cloned C-terminal third of UL9 did not show 
cooperative binding and was a monomer in solution. Footprinting analyses indicate that 
binding of UL9 induces a major change of conformation at the origin, the protein possibly 
forming a higher order structure by winding the DNA around itself (Elias et al, 1990; Koff 
et al, 1991; Fierer and Challberg, 1992). UL9 is a helicase displacing an oligonucleotide 
bound to M13 in the presence of ATP. Inclusion of a free 3’ or 5' tail on the 
oligonucleotide facilitated the action of the helicase suggesting that it is displaced from 
one end rather than the middle, and indicating a 3 -5 ' polarity of helicase action (Bruckner 
et al, 1991; Fierer and Challberg, 1992). If the action of UL9 was analogous to that of 
SV40 large T antigen, UL9 would unwind the DNA around the origin after binding. 
However UL9 does not cause unwinding of a plasmid containing origin sequences, 
although a conformational change is induced. This change occurs in the absence of ATP 
(Fierer and Challberg, 1992). Thus UL9's helicase activity is independent of its origin-
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binding activity. Much remains to be discovered about UL9 and its interaction with origin 
sequences.
Some of the sequences flanking the core origin of oris stimulate replication (Stow 
and McMonagle, 1983; Wong and Schaffer, 1991; Dabrowski and Schaffer, 1991). The 
sequences required were the promoter regulatory elements of the IE 175 and IE68 / IE 12 
genes (which are divergently transcribed around ori^ but not the transcript start sites 
themselves. Cotransfection of the flanking sequences on another plasmid titrated out the 
stimulating effect of flanking sequences in the origin-containing plasmid, suggesting 
removal of a diffusible factor mediating the stimulation. Replacement of the sequences 
with another promoter (HCMV immediate-early promoter) produced wild type levels of 
replication. These results are consistent with an unknown cellular protein (or proteins) 
binding to the required sequences thereby stimulating replication. The flanking regions 
do contain consensus binding sites for a number of transcriptional activator proteins such 
as Spl and NF1 but binding of these proteins has not been examined. Reconstruction of 
origin-dependent HSV-1 DNA replication in vitro should allow detailed examination of 
stimulation by the flanking regions.
ii) Priming.
During HSV DNA replication the parental DNA helix must be continually 
unwound and the lagging strand primed for the DNA polymerase. These activities can 
probably be assigned to the viral helicase-primase enzyme.
A virus specific helicase activity was partially purified from infected cells in 1988 
(Crute et al, 1988). This enzyme has since been purified to homogeneity and been shown 
to have helicase and primase activity and to consist of the proteins UL5, UL8, and UL52, 
three of the viral gene products required for origin dependent DNA replication (Crute et 
al, 1989; Wu et al, 1988). The enzyme's catalytic properties have been thoroughly 
examined (Crute et al, 1989; Crute and Lehman, 1991; Sherman et al, 1992) and it has 
been overexpressed using the baculovirus expression system and purified from this source 
(Dodson et al, 1989). The purified enzyme has a molar mass of approximately 263,000 
daltons and is a 1:1:1 heterotrimer of UL5, UL8, and UL52 (Crute and Lehman, 1991). 
The catalytic properties of the enzyme are listed below (table 8).
44
Introduction: HSV DNA replication
Table 8. Properties of the HSV-1 helicase-primase.
Primase Helicase
pH optimum:
Free Mg2+ requirement: 
Template:
8.5-9.0
1.5 mM
poly dT and M l3 suitable
active 5.5-9.0 
1-10 mM
unpaired region required
Size of primers synthesised: 10-12 nt or 6 nt
Rate and polaritya of 
helicase activity:
1 base pair per 
second, 5-3*
a With respect to the strand to which it is bound.
The primase has very sharp pH and magnesium concentration optima, but mo 
apparent template specificity being active on M 13 or poly dT. Conflicting results ha:ve 
been published concerning the predominant size of the primers synthesised, 10-12 
nucleotides and 6-8 nucleotides respectively being claimed (Crute and Lehman, 1991; 
Sherman et al, 1992). Thus the HSV-1 primase is similar to other eukaryotic primases.
The helicase activity of the helicase-primase complex is tolerant of wide pH amd 
magnesium concentration changes. It displaces annealed oligonucleotides from M13 in ;an 
ATP-dependent manner, functioning better if displacing an oligonucleotide with a 3' 
unpaired tail than one with a 5' unpaired tail. The helicase activity is stimulated in the 
presence of the HSV-1 single stranded DNA-binding protein ICP8. Altogether, studies 
suggest that the helicase moves 5' to 3' along the strand to which it is bound. The 
measured rate of helicase action in vitro is much slower than the rate of movement olf a 
pseudorabies virus replication fork which was measured at 50 nucleotides per second at 
37 °C (Ben-Porat et al, 1977). (Pseudorabies virus is a member of the a  herpesviirus 
family and shows many similarities to HSV.) However the rate of the HSV-1 helicaise 
might be expected to increase substantially in the presence of other HSV-1 replicatiion 
proteins. The helicase has two NTPase sites; site I hydrolyses GTP or ATP and £te; II 
ATP only. They have different turnover rates and Km's and each is activated by a dijtimct 
DNA effector site which supports helicase action (Crute et al, 1991). The helicase miay 
therefore bind both arms of a DNA fork.
A major step forward in localising the different activities of the compljx to 
particular protein chains has been the observation that a stable subassembly (compojed of 
proteins UL5 and UL52) has helicase and primase activities, and that these activities are 
indistinguishable from those seen with the full complex (Calder and Stow, 1990; Dodsjon 
and Lehman, 1991), with one exception to be discussed below. So far none cf tthe
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polypeptides composing the complex have been shown to be active alone as either 
helicase or primase. It has been observed that the amino acid sequence of the UL5 protein 
contains six regions that are conserved in all members of a superfamily of DNA and RNA 
helicases. One of these sequences is a consensus ATP-binding site (McGeoch et al, 
1988b; Zhu and Weller, 1992). The six conserved regions, but not non-conserved regions, 
have been shown by directed mutation to be essential for the helicase function of the 
complex (Zhu and Weller, 1992). By exclusion it would appear that UL52 is primarily 
involved in primase activity but it is possible that UL5 and UL52 together constitute both 
the helicase and primase active sites. UL8 influences the cellular localisation of the 
UL5/UL8/UL52 complex (Calder et al, 1992). UL5 and UL52 form a complex in HSV 
infected cells in the absence of UL8 but this complex is not efficiently localised to the 
nucleus. Therefore one role of UL8 may be to facilitate nuclear transport.
As noted above, the UL5/UL8/UL52 complex and the UL5/UL52 subassembly 
have identical helicase and primase activities. Primase activity is measured in an indirect 
assay, in which a poly dT template primed by the enzyme under test, is the substrate for a 
DNA polymerase incorporating radiolabelled dNTPs. When the same assay was 
performed with M l3 as template a much lower activity was observed for the UL5/UL52 
subassembly than for the full complex (Sherman et al, 1992). This was puzzling as the 
size of the primers made by the two complexes on M13 was the same. Further 
experiments showed that DNA synthesis by HSV-1 polymerase (UL30/UL42 complex) on 
ICP8-coated, single stranded M l3 could be primed by UL5/UL8/UL52 complex but not 
by the UL5/UL52 complex. The full reaction was referred to as lagging strand synthesis. 
Mixing of partially purified UL8 with UL5/UL52 restored most of the activity of the full 
complex in the lagging strand synthesis reaction. Effective priming by UL5/UL8/UL52 
but not by UL5/UL52 was also seen when E. coli pol I was used instead of HSV-1 
polymerase. Two explanations for this effect are possible: (i) a specific link between the 
primase and HSV-1 DNA polymerase mediated by UL8 and (ii) stabilisation of bound 
primers by the UL5/UL8/UL52 complex, again mediated by UL8. The results with the E. 
coli DNA polymerase suggest that the former is not the correct explanation unless 
considerable structural homology has been maintained in these distantly related 
polymerases. Primer stabilisation by UL8 seems the most likely explanation and would 
explain the template dependence of the UL8 effect. With a template of low complexity 
(such as poly dT) the short primers synthesised by the HSV-1 primase would reassociate 
quickly despite their high rate of dissociation at physiological temperatures. On a 
template of high sequence complexity such as M13 or natural HSV-1 DNA, reassociation 
at the specific site to which the primer was complementary would be so slow as to render 
priming ineffective. Therefore a mechanism for maintaining the integrity of primer 
template complexes is required. This function appears to be performed by UL8.
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The T4 bacteriophage helicase/primase, comprising proteins 41 and 61, may have a 
similar system to HSV-1 for stabilising primers (Nossal and Hinton, 1987; Sherman et al, 
1992). Together these proteins synthesise 5 nucleotide primers which are elongated by 
the viral polymerase. Gene 61 protein alone makes mostly 2 nucleotide primers, with 
traces of 5-45 nucleotide primers. Only the longer primers are elongated by the viral 
polymerase, presumably due to their greater stability. Nossal and Hinton propose that the 
gene 41 protein stabilises the 5 nucleotide primers synthesised by the full helicase/primase 
on the template. This seems analogous to the system proposed for HSV-1.
I t has been proposed that a complex of two proteins Ci and C2 operates in 
eukaryotic cells as a primer recognition system (Pritchard and DePamphilis, 1983; 
Pritchard et al, 1983; Vishwanatha et al, 1992). The C1C2 complex increases the 
efficiency with which eukaryotic polymerase a-primase uses substrates with low primer 
to tem plate ratios. The C1C2 complex binds to the polymerase a-primase so that a close 
association of the complex with primase is possible. However unlike UL8, the complex 
binds to single stranded (but not double stranded) DNA and exerts its effects even on 
substrates of low complexity. Therefore a different mechanism of action is probably 
involved.
iii) Elongation.
The viral DNA polymerase.
HSV-1 DNA is synthesised by the viral polymerase (Pol) the product of gene 
UL30 (pol). Drug resistant mutants with an altered DNA polymerase map to this gene 
strongly suggesting that its product is the catalytic protein (Purifoy et al, 1977; Chartrand 
et al, 1980; Coen et al, 1984). This suggestion was confirmed by the expression of the 
cloned UL30 gene which gave the HSV-1 polymerase activity (Dorsky etal, 1987; Marcy 
et al, 1990). There has been considerable interest in the UL30 gene product due to its 
potential as a drug target and the insight it gives into related eukaryotic DNA 
polymerases. The UL30 gene product possesses catalytic activity in the absence of other 
proteins but has low processivity on templates with significant regions of single stranded 
DNA (Gottlieb et al, 1990; Hernandez and Lehman 1990). It has a 3'-5' exonuclease 
(Knopf, 1979; O'Donnell et al, 1987) and also a 5'-3’ exonuclease or RNaseH activity 
which may act to remove primers (Crute and Lehman, 1989). The regions of the protein 
chiefly responsible for the catalytic activities have been localised by studies of drug 
resistant mutants and by comparing the amino acid sequence of UL30 to homologous 
DNA polymerases of other organisms. As mentioned earlier comparison reveals six 
regions of homology (named I to VI, in order of decreasing similarity) which are 
conserved between UL30 and the polymerases of a number of eukaryotes and viruses
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(Larder et al, 1987; Wong et al, 1988). UL30 has greatest similarity to human polymerase 
5. UL30 mutants with altered sensitivity to nucleotide and pyrophosphate analogues and 
aphidicolin, have mutations predominantly in regions I, n , and III (residues 881-896, 694- 
736, and 805-845 respectively) (Tsurumi eta l, 1987; Gibbs e ta l, 1985; 1988; Hall et al, 
1989; Marcy et al, 1990). It is therefore likely that these regions are directly involved in 
substrate and drug binding and the polymerising activity of the enzyme. Limited 
homology to conserved regions of bacterial and bacteriophage DNA polymerases has led 
to the proposal that region IV (residues 432-479) is essential for 3 -5 ' exonuclease 
activity, and that sequences near the amino terminus of the protein (248-262) are involved 
inRNaseH activity (Bernad etal, 1989; Reha-Krantz, 1989; 1990).
The product of gene UL42 was identified initially as a DNA-binding protein with 
a molar mass of 65,000 daltons (Bayliss et al, 1975; Vaughan et al, 1985; Marsden et al, 
1987; Parris et al, 1988). The protein is required for viral growth and DNA synthesis 
(Marchetti et al, 1988; Johnson et al, 1991) and forms a heterodimer with the viral DNA 
polymerase (Gallo et al, 1988; Crute and Lehman, 1989; Gottlieb et al, 1990). The 
protein functions as an accessory factor of Pol, increasing the rate of incorporation of 
deoxynucleotide triphosphates into activated DNA (Gallo et al, 1989) and increasing the 
processivity of Pol on a defined template-primer (Gottlieb et al, 1990; Hernandez and 
Lehman, 1990). The physical association of Pol and UL42 parallels that observed 
previously between HSV-2 ICP34,35 and HSV-2 DNA polymerase (Vaughan et al, 1985). 
ICP34,35 has subsequently been shown to be the HSV-2 equivalent of UL42 protein 
(Gallo et al, 1989). The effect of UL42 on the rate of catalysis of the enzyme is 
dependent on the concentration of salt in the assay (Hart and Boehme, 1992). 
Footprinting of the full enzyme and its individual subunits on a defined template (a short 
double stranded DNA with a 5' single stranded overhang) showed that the isolated 
catalytic subunit binds to a region centred on the recessed 3' end, protecting 15 base pairs 
of double stranded DNA and 18 nucleotides of the unpaired region. Inclusion of UL42 
protects an additional 5 base pairs of the double stranded region next to the UL30 binding 
site without affecting the unpaired region. UL42 alone bound non-specifically to the 
double stranded DNA. Filter binding and gel shift assays suggest that UL42 increases the 
affinity of UL30 for the model substrate by 5-10 fold (Challberg, 1991).
Physical interaction of UL30 and UL42 is required for DNA replication but not for 
basal polymerase activity (Digard et al, 1993; Stow, 1993). The final 227 residues of 
UL30 are sufficient for its interaction with UL42 (Digard and Coen, 1990) although 
attempts to map the region of interaction more precisely have given conflicting results 
(Tenney et al, 1993; Digard et al, 1993; Stow, 1993). Some portion of the last 60 amino 
acids of the polymerase is probably required. The portion of UL42 forming the interface 
with UL30 has not been determined (Owsianka et al, 1993).
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The major DNA-binding protein ICP8.
The major HSV-1 DNA-binding protein ICP8 was identified as a 130 kD nuclear 
protein that bound tightly to single stranded DNA columns (Bayliss et al, 1975; Purifoy 
and Powell, 1976; Powell etal, 1981; Fenwick et al, 1978; Knipe and Spang 1982). It has 
many of the properties of helix destabilising proteins, binding more tightly to single than 
double stranded DNA and binding to single stranded DNA in a cooperative and sequence 
independent manner (Ruyechan, 1983; Ruyechan and Weir, 1984). Therefore ICP8 may 
be analogous to gene 32 protein of T4 bacteriophage and E. coli SSB protein. It is a 
matter of dispute whether processive replication of long single stranded DNA molecules 
by the UL30/UL42 complex requires ICP8 (Hernandez and Lehman, 1990; Gottlieb et al, 
1990). E. coli single stranded DNA-binding protein SSB may be able to substitute for 
ICP8 iin this reaction (O'Donnell et al, 1987). Interestingly, affinity chromatography 
experiments show that ICP8 interacts strongly with the viral alkaline nuclease and rather 
more weakly with UL42 (Vaughan et al, 1984). This result has been confirmed for 
alkaline nuclease by co-immunoprecipitation (Thomas et al, 1992). It is possible that 
ICP8 also interacts with other HSV-1 proteins.
ICP8 appears to play a role in organisation of viral DNA replication in the infected 
cell. Early electron microscopic autoradiography experiments (Rixon et al, 1983) showed 
that HSV DNA replication began at small, discrete sites that grew into large globular 
replication compartments that eventually filled the whole nucleus. It was later shown that 
ICP8 localised to probably identical early 'pre-replicative sites' and relocalised to 
'replicative sites' as DNA replication progressed (Quinlan et al, 1984). Both types of site 
are strongly associated with the nuclear matrix. Other HSV-1 DNA replication proteins 
localised to replicative sites in a process that was dependent on functional ICP8 (De 
Bruyn Kops and Knipe, 1988; Bush et al, 1991; Calder et al, 1992). A number of cellular 
proteins with DNA- or cell proliferation-associated functions also co-localised with ICP8 
at these sites. These included cellular single stranded DNA binding protein (RF-A); 
proliferating cell nuclear antigen (PCNA) the polymerase 8 processivity factor; 
retinoblastoma protein; p53 'anti-oncogene' protein; DNA ligase I and cellular DNA 
polymerase a  (Wilcock and Lane, 1991). These results are especially interesting given 
that it is not known whether any cellular proteins are involved in HSV-1 DNA replication, 
either during initiation or at the replication fork. HSV-1 does not appear to encode a 
ligase or topoisomerase, enzymes that are likely to be required for complete replication of 
the viral genome, and so these may be supplied by the cell.
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In addition to proteins directly involved in DNA replication, HSV-1 encodes a 
number of enzymes that are involved in DNA and nucleotide metabolism. These are 
thymidine kinase (Kit and Dubbs, 1963); ribonucleotide reductase (Cohen, 1972); 
deoxyuridine triphosphatase (dUTPase, Wohlrab and Francke, 1980; Fisher and Preston, 
1986); uracil-DNA glycosylase (Caradonna et al, 1987); and alkaline nuclease (Keir and 
Gold, 1963).
Thymidine kinase.
The HSV-encoded thymidine kinase (TK) phosphorylates thymidine (Kit and 
Dubbs, 1963), other deoxypyrimidine nucleosides, and some nucleoside analogs 
(Jamieson et al, 1974; Elion, 1982). Several anti-HSV drugs, for example acyclovir, are 
activated by TK, and mutations in the TK gene can lead to resistance to such drugs (Fyfe 
et al, 1978; Field et al, 1980; Coen and Schaffer, 1980; Schnipper and Crumpacker, 
1980). The involvement of TK in viral pathogenesis is therefore of continuing interest.
TK is not required for virus growth in rapidly growing cultured cells, but TK 
minus mutants are impaired for growth in serum-starved cells (Field and Wildy, 1978; 
Jamieson et al, 1974). TK mutants grow inefficiently in nervous system tissues and have 
reduced pathogenicity when innoculated intracerebrally (Field and Darby, 1980). 
Available evidence suggests that TK minus mutants can establish latency but that they 
reactivate less frequently (Coen etal, 1989; Efstathiou et al, 1989).
Ribonucleotide reductase.
Ribonucleotide reductase (RR) plays a vital role in producing precursors for DNA 
synthesis by reducing ribonucleotides to deoxyribonucleotides. The HSV enzyme 
(Cohen, 1972) is composed of two subunits R1 (large) and R2 (small). These are 
homodimers of 140 kD and 38 kD proteins, the products of genes UL39 and UL40 
(Huszar and Bacchetti, 1981; Anderson et al, 1981; Dutia, 1983; Preston, V.G. et al, 
1984; Frame et al, 1985). Unlike cellular enzymes the HSV ribonucleotide reductase is 
not feedback inhibited by deoxynucleotide triphosphates (Huszar and Bacchetti, 1981).
Studies of temperature sensitive mutants and deletion mutants show that RR is not 
required in exponentially growing monkey cells at 37 °C, but is required in serum starved 
cells or those growing at 39.5 °C (Preston, V.G. et al, 1984; Goldstein and Weller, 
1988b). The latter result appears to be due to the thermolability of some cellular or viral 
component that substitutes for RR during growth of mutants at 37 °C ( Preston, V.G. et 
al, 1988; Goldstein and Weller, 1988c). This component may be the cellular 
ribonucleotide reductase.
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Analysis of RR mutants in animal models (Cameron et al, 1988) indicates that the 
enzyme is required for virulence in mice and reactivation from latency (Jacobsen et al, 
1989) but not for virulence in guinea pigs (Turk et al, 1989). RR mutants grow to 100- 
fold lower titre in primary human corneal fibroblasts suggesting that the enzyme is a valid 
antiviral target in humans (Brandt et al, 1991). There is considerable interest in inhibiting 
RR with targeted antiviral drugs, and more active compounds have been developed from a 
lead peptide which specifically inhibits the viral enzyme (Dutia et al, 1986; Cohen et al, 
1986; reviewed in Marsden, 1992).
Deoxyuridine triphosphatase (dUTPase).
HSV-1 dUTPase catalyses the conversion of dUTP to dUMP and pyrophosphate 
(Wohlrab and Francke, 1980; Caradonna and Cheng, 1981). This reaction reduces the 
quantity of uridine incorporated into replicating DNA and also provides a source of 
dUMP for conversion to dTMP by thymidylate synthetase. The reaction is important for 
HSV-1 as the viral DNA polymerase is able to use dUTP as a substrate (Williams, 1984).
The viral dUTPase is not required for HSV-1 to grow in cultured cells even when 
the cells are restricted in their growth (Fisher and Preston, 1986). Pyles and colleagues 
(1992) investigated the growth of dUTPase deletion mutants in mice. The mutant viruses 
had reduced virulence and grew to reduced titres in the central nervous system despite 
growing to wild type levels in epithelial and peripheral nervous system tissue. Latent 
infections were established but reactivation was much less frequent.
Uracil DNA glycosylase.
This DNA repair enzyme removes uracil residues from DNA. Such residues can 
arise by misincorporation of dUTP during replication or via the deamination of cytosine. 
The HSV-1 uracil DNA glycosylase, first reported by Caradonna and Cheng (1981), is 
encoded by gene UL2 (Worrad and Caradonna, 1988; Mullaney et al, 1989). A mutant 
lacking the enzyme grows to the same titre as wild type virus in a single step growth 
experiment (Mullaney et al, 1989). Studies of mutant viruses in animal models have not 
been carried out.
Alkaline nuclease.
Infection of cells by HSV-1 or HSV-2 results in the induction of a novel enzyme 
activity, alkaline nuclease (Keir and Gold, 1963; Hoffmann and Cheng, 1978). Alkaline 
nuclease purified from HSV-infected cells exhibits exo- and endonuclease activities and 
differs from host cell nucleases in its biochemical properties, especially its high pH  
optimum (Morrison and Keir, 1968; Hoffman and Cheng, 1978; 1979; Francke et al, 
1978; Streobel-Fidler and Francke, 1980). The isolation of a temperature-sensitive mutant 
showed that the enzyme was encoded by the virus (Francke et al, 1978). This finding was
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confirmed by the induction of alkaline nuclease activity in Xenopus oocytes following 
injection of HSV DNA (Preston and Cordingley, 1982). The nuclease is not involved in 
viral DNA synthesis but probably plays a role in processing and packaging of viral DNA 
(Weller etal, 1990).
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All chemicals were Analar grade or equivalent and were supplied by BDH or Sigma 
unless noted.
Peptide synthesis chemicals.
Dimethyl formamide (DMF), piperidine, ether, trifluoroacetic acid (TFA) and 
acetonitrile were supplied by Rathbum Chemicals. Anisole and ethanedithiol (EDT) were 
from Aldrich. Derivatised amino acids were supplied by Pharmacia LKB or Novabiochem. 
Amino acid-linked resins were purchased from Peptide and Protein Research Consultants, 
Exeter, UK.
Production of antisera and monoclonal antibodies.
Rabbits and mice were supplied by Hylyne. Freund's adjuvant (complete and 
incomplete) was supplied by Sigma or Life Technologies. Pristane was supplied by Sigma.
EUSA assays.
Immulon 1 plates and strips were supplied by Dynatech. Conjugates for detection 
purposes were supplied by Sigma.
SDS polyacrylamide gels.
Acrylamide was supplied by Koch-Light Ltd or BDH and ammonium persulfate, 
tetramethylethylenediamine (TEMED) and Coomassie Brilliant Blue R250 were from Bio- 
Rad.
Tissue culture reagents.
Glasgow modified Eagles medium, Dulbecco's modified Eagles medium, TCI00 
medium, sodium bicarbonate solution, glutamine, penicillin, streptomycin, new bom calf 
serum, and foetal calf serum for hybridoma cells were all supplied by Life Technologies. 
Foetal calf serum for S. frugiperda cells was supplied by Advanced Protein Products. 
Tissue culture flasks were from Falcon.
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Western blotting.
Nitrocellulose for Western blotting was supplied by Schleicher and Schuell. Gelatin 
and colour development reagent 4-chloro-l-naphthol were from Bio-Rad. Horseradish 
peroxidase conjugates were obtained from Sigma.
Radiochemicals.
All radiochemicals were supplied by Amersham.
Chromatography of proteins.
All chromatography matrices and pre-packed columns were obtained from 
Pharmacia.
DNA band shift assays.
Oligonucleotides were synthesised on a Biosearch 8600 automated DNA synthesiser 
(Applied Biosystems) and purified on a 15% acrylamide DNA sequencing gel. Duplex 
oligonucleotides were formed by mixing equivalent masses of the two complementary 
strands, heating to 95 °C and allowing to cool slowly to room temperature.
T4 polynucleotide kinase was obtained from New England Biolabs. T4 bacterio­
phage gene 32 protein and T7 bacteriophage RNA polymerase were obtained from 
Boehringer Mannheim and New England Biolabs respectively. HSV-1 UL42 protein was 
purified by the method of Gallo et al (1988).
54
Materials
BUFFER SOLUTIONS
T buffer: 10 mM triethanolamine pHl.5 (HC1)
10 mM KC1
1.5 mM MgCl2 
1 mMDTT 
0.5 mM PMSF
10 pg/ml leupeptin 
10 pg/ml pepstatin A
Reticulocyte standard buffer (RSB):
10 mM tris pH7.5 (HC1)
10 mM KC1
1.5 mM MgCl2 
1 mMDTT
Phosphate buffered saline (PBS):
136 mM NaCl
2.6 mM KC1
8 mM Na2HP04
1.4 mM k h 2p o 4
0.7 mM CaCl2
0.5 mM MgCl2
Tris buffered saline (TBS):
20 mM tris pHl.5 
0.5 M NaCl
Towbin blotting buffer:
25 mM tris 
192 mM glycine
20% methanol (v/v) pH  8.3 (HC1)
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Synthesis of peptides.
Synthesis:
Peptides were synthesised using Fmoc solid phase chemistry (Atherton and 
Sheppard, 1989) and its associated standard procedures on a Biolynx automated peptide 
synthesiser (LKB Biochrom now Novabiochem) with software provided by the company. 
The resins used were Dimacryl KA resin with the carboxy terminal amino acid attached for 
single chain peptides and K7A-Dimacryl KA resin for branched chain peptides.
Peptides were cleaved using 95% TFA in water plus the appropriate scavengers for 
the peptide’s sequence. After cleavage peptides were washed by ether extraction, dissolved 
in water and lyophilised. The lyophilised peptides were stored at -20 °C.
A nalysis:
Single chain peptides were analysed by Fast Atom Bombardment mass spectrometry 
(FAB-MS) by M-Scan Ltd, Ascot, Berkshire, UK.
Amino acid analysis of branched peptides was performed by Cambridge Research 
Biochemicals Ltd.
A Beckman System Gold instrument was used for high pressure liquid 
chromatography (HPLC) with a Dynamax reversed phase column (C8, 4.1 ml bed volume; 
Anachem). A gradient from 0.1% TFA in water to 0.05% TFA, 95% acetonitrile in water, 
was applied over 10 ml at a flow rate of 0.5 ml/min. Peptides were detected by their 
absorbance at 205 nm and peaks were scanned (190-304 nm) to confirm that their 
absorbance profiles were characteristic of peptides.
Production of rabbit antipeptide and antiprotein sera.
Half sandy lop rabbits were pre-bled and their sera screened by Western blotting for 
reactivity against HSV-1-infected cell extracts and baculovirus-infected cell extracts. Rabbits 
whose sera showed no reactivity were used for immunisations. Peptide or protein solutions 
emulsified 1:1 with Freund’s complete adjuvant (for the initial injection) or incomplete 
adjuvant (for subsequent injections) were injected intramuscularly into the hind limb. One 
hundred micrograms of peptide or 8-50 pg of protein were used per rabbit per injection. 
Test bleeds were screened for positive reaction on Western blot. Typically, animals were 
injected on days 0, 10, 30, and 40, test bled on day 39 and ex sanguinated under deep 
anaesthesia on day 50.
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SDS polyacrylamide gels.
Sodium dodecyl sulfate (SDS) polyacrylamide gels for proteins used the buffer 
system of Laemli (1970). All resolving gels were 10% acrylamide with V40th the quantity 
of N,N' methylenebisacrylamide unless otherwise stated. Resolving gels were made up to 
give a final buffer concentration of 375 mM tris, 3.5 mM SDS, pH 8.9 (HC1). Stacking gel 
with wells for samples was 5% acrylamide in 125 mM tris, 3.5 mM SDS, pH 6.7 (HC1). 
Gels were polymerised using a final concentration of 0.1% ammonium persulfate and 0.1% 
tetramethylethylenediamine (TEMED). Running buffer for the gels was 50 mM tris, 
50 mM glycine and 3.5 mM SDS. Samples to be loaded onto gels were mixed 2:1 with 
boiling mix (0.15 M tris pH 6.7, 30% glycerol, 0.21 M SDS, 2.1 M (3-mercaptoethanol) 
and heated for 5 minutes at 90 °C before loading.
Proteins were detected by staining with 0.2% Coomassie Brilliant Blue R250 in 47% 
methanol, 6% acetic acid in water and destained in water containing 5% methanol, 7% acetic 
acid. Scanning of stained SDS polyacrylamide gels was performed using a Hoefer Scientific 
Instruments (San Francisco, California, USA) GS 300 transmittance/reflectance scanning 
densitometer with a GS 360 data system from the same company run on an IBM personal 
computer.
Gels for figures were copied onto Kodak Electrophoresis duplicating paper before 
drying or dried and then photographed. Gels were dried for preservation onto Whatman 
filter paper using heat and vacuum.
Preparation of HSV-1 infected cell extracts for protein gels.
Baby hamster kidney (BHK) 21 clone 13 cells (Macpherson and Stoker, 1962) were 
grown in 850 cm2 tissue culture roller bottles in Glasgow modified Eagles medium 
supplemented with 0.25% NaMCOs, 4 mM glutamine, 100 IU/ml penicillin, 100 pg/ml 
streptomycin, 10% tryptose phosphate broth, and 10% new-born calf serum. Medium was 
removed from 80% confluent monolayers and 10 plaque forming units (pfu) per cell of low 
passage working stock of HSV-1 17+ (Brown et al, 1973) was added in identical medium 
except that it contained only 20% of the methionine and only 2% serum. Two hours post 
infection (2 hpi) the infecting stock was removed and 10 MBq of 35S-methionine was added 
in the same medium. Sixteen hours later the cell monolayer was washed three times with 
PBS and the cells were removed by heating in 50 mM tris pH 6.7, 10% glycerol, 70 mM 
SDS, 0.7 M p-mercaptoethanol. These extracts were used at a concentration of 1.3 x 106 
cell equivalents per cm width of gel.
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*(1 hour at 37°C; all other Western blotting procedures were carried out at room temperature 
except where noted)
~^4-chloro-1 -naphthol and hydrogen peroxide were used at 0.05% and 0.015% respectively ia 
TBS containing 16% methanol. ‘
Methods
Western blotting.
Protein mixtures separated on SDS polyacrylamide gels were transferred to 
nitrocellulose membrane by electroblotting using a Bio-rad transblot tank run at 0.25 amps 
for three hours. The buffer system of Towbin et al, (1979) was used. Non-specific 
binding sites on membranes were blocked using 3% gelatin in TBS before the addition of 
antisera diluted in TBS containing 0.05% Tween 20 and 1% gelatin. Diluted antisera were 
incubated on the membrane for 2 hours at 37 °C or overnight at room temperature. After 
extensive washing in TBS containing 0.05% Tween 20 (TIBS), HRP conjugated protein A 
(for rabbit antisera) or HRP conjugated goat anti-mouse IgG was added, diluted in 1% 
gelatin TTBS, and incubated for 1 hour. After further washing in TTBS followed by TBS, 
blots were developed using 4-chloro-l-naphthol and hydrogen peroxide: Development was 
stopped by washing with deionised water and blots were dried and conserved in the dark.
Growth of S. frugiperda  cells and Autographa californica  n u c l e a r  
polyhedrosis virus.
Spodoptera frugiperda Sf9 cells (strain IPLB-Sf-21, Summers and Smith, 1987) 
(abbreviation Sf) were grown at 28 °C in tissue culture dishes or flasks in TCI00 medium 
supplemented with 5% foetal calf serum, 100 IU/ml penicillin and 100 pg/ml streptomycin.
Cells were routinely divided 1 to 9 every three days.
Wild type Autographa calif ornica nuclear polyhedrosis virus (AcNPV or 
baculovirus), and its recombinants, were grown on monolayers of Sf cells. Virus was 
inoculated onto approximately 75% confluent monolayers of cells and the medium harvested 
as virus stock three days later. Virus stock was stored at 4 °C or at -70 °C.
Precipitation of proteins with ammonium sulfate.
Finely ground solid ammonium sulfate was added slowly with agitation to protein 
solutions on ice. Solutions were then incubated for 10 minutes at room temperature or 4 °C 
with end over end mixing before being centrifuged for 10 minutes at room temperature in a 
benchtop |microfuge.
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Purification of UL8 protein.
Methods
Harvesting of infected cells and production of crude extract:
Sf cells (eight 175 cm2 flasks) were infected with recombinant baculovirus AcUL8 
(Calder and Stow, 1990) and harvested 60-70 hours later by shaking the cells into the 
medium and pelleting at 1860g. Medium was retained as virus stock. The cells were 
washed by resuspension in 10 ml of TBS per flask and repelleted. The cell pellet was 
resuspended in ice cold buffer G (see overleaf) without NP40, and then NP40 was added to 
give a final volume of 400 pi of buffer per flask. The cell suspension was incubated for 10 
minutes on ice, centrifuged for 2 minutes at 10,000g and the supernatant removed and 
centrifuged at 175,000g for 30 minutes at 4 °C. The supernatant from this second 
centrifugation step (the crude extract) was frozen at -70 °C until required.
Fractionation of the crude extract:
Initial fractionation was performed using diethylaminoethyl (DEAE) sepharose. 
Thawed crude extract (4 ml) was centrifuged at 10,000g and loaded onto a 2 ml column 
equilibrated in buffer A. The column was washed with 10 ml of the same buffer and a 14.3 
ml gradient of 100 mM to 350 mM NaCl in buffer B was run. UL8 protein eluted between 
240 mM and 340 mM NaCl. A new column was packed for each purification. The UL8 
containing fractions (seen as a distinct peak in the UV trace and previously identified by SDS 
polyacrylamide gel electrophoresis) were loaded onto a 5 ml phenyl sepharose column 
(Pharmacia, Low substitution Fast flow) equilibrated in buffer B containing 100 mM NaCl. 
The column was washed with 10 ml of this buffer before a 10 ml gradient to 100% buffer C 
was applied. UL8 protein eluted at the end of this gradient as a symmetrical peak in the 
280 nm absorbance profile. Yield was approximately 1.5 mg of UL8 protein. Purity was 
estimated at 95% by scanning of a Coomassie blue stained SDS polyacrylamide gel.
Some early preparations of UL8 were passed through a superose 12 gel filtration 
column. However as this did not significantly increase purity, this step was not employed 
for subsequent preparations.
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Buffers used in the purification:
Methods
Buffer G 20 mM triethanolamine pRl.5  (HC1)
10% glycerol 
10 mM KC1
1.5 mM MgCl2 
1 mM dithiothreitol (DTT)
0.5 mM phenylmethylsulfonyl fluoride (PMSF)
0.5% NP40 
10 fig/ml leupeptin 
10 |ng/ml pepstatin A
Buffer A 20 mM triethanolamine pK1.5 (HC1)
10% glycerol 
0.1 M NaCl
Buffer B 20 mM tris pH8.0 (HC1)
10% glycerol
Buffer C H20 , 10% glycerol, 4 °C
Measurement of protein concentrations.
Protein concentrations were measured using a Pierce Bicinchoninic acid (BCA) 
protein assay kit with a solution of bovine serum albumin (BSA) also from Pierce as 
standard. Colour changes were detected at 562 nm using a Beckman DU-62 UV/Visible 
spectrophotometer.
Gel filtration chromatography.
Approximately 60 pg of purified UL8 protein in 150 |il of buffer was added to a 
25 ml Pharmacia superose 12 gel filtration column equilibrated in 20 mM triethanolamine 
pH  7.5, 10% glycerol, 0.2 M NaCl. The column was run at 0.2 ml/minute in the same 
buffer. Molecular mass standards (Sigma) were dissolved at a concentration of 1 mg/ml in 
water and clarified by centrifugation before use.
60
DNA band shift assays.
Methods
Preparation of DNA:
The oligonucleotides used are represented below. When annealed they are identical 
to oligonucleotide I of Weir and Stow (1990), and the boxed portion represents box I of oris 
(a UL9 binding site) identified by these authors. However the DNA was used as a non­
sequence-specific probe.
The oligonucleotides were supplied by Dr N. D. Stow in purified form.
5' labelling:
Single stranded DNA (oligonucleotide 2; 1 pg), partially double stranded DNA 
(annealed oligonucleotides 1 and 2; 1 pg), and DNA/RNA hybrids (poly(rA).oligo(dT)12_18, 
Pharmacia, 10 pg) were 5' labelled using T4 bacteriophage polynucleotide kinase and y-32P 
ATP (20 pCi per reaction) in kinase buffer: 50 mM tris HC1 pH 7.6, 10 mM MgCl2, 0.1 
mM EDTA, 0.1 mM spermidine, 5 mM DTT for 30 minutes at 37 °C. Oligonucleotides 
were purified by phenol/chloroform extraction after labelling, ethanol precipitated, and 
resuspended in water for storage at -20 °C.
3' labelling:
Fully double stranded DNA was produced by 3' labelling annealed oligonucleotides 
1 and 2 (200 ng) using Klenow fragment of E. coli polymerase and a -32P GTP (20 pCi) 
the firs;t complementary nucleotide, for 30 minutes at room temperature followed by a chase 
with excess of all four cold nucleotides for 15 minutes also at room temperature. The buffer 
used was: 50 mM tris HC1 pH 7.6,10 mM MgCl2, 1 mM DTT, 50 pg/ml BSA (restriction 
enzyme grade). The 3' labelled oligonucleotide was purified and stored in the same manner 
as the 5' labelled oligonucleotides.
DNA-protein binding reactions:
DNA-protein binding reactions were carried out in GRA buffer: 50 mM HEPES pH 
7.8 (NaOH), 10% glycerol, 50 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT or 
the same buffer without sodium chloride or magnesium chloride (low salt GRA). All 
reactions also contained 100 pg/ml BSA and had a final volume of 20 pi. The reaction 
mixtures were incubated at 37 °C for 20 minutes, unless otherwise stated. Five microlitres 
of loading buffer (25% glycerol, 10 mM DTT, 0.01% bromophenol blue, all in TBE) was 
then added before electrophoresis.
1
2
GATCCGCGA AGCGTTCGCACTTCGTC CCA
GCGCT TCGCAAGCGTGAAGCAG GGTCTAG
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* Wells were coated with 50 j l i I  of protein solution and incubated overnight at 37°C (Where I 
necessary UL8 was diluted in water containing 10% glycerol). The wells were washed five 
times with ‘ELISA’ PBS tween (EPT) and blocked with lOOjxl of 0.5% BSA in EPT for 
1 hour at 37°C. The first antibody was added diluted in 0.5% BSA-EPT (50|al) and was 
left in the wells for 1 hour at 37°C. The wells were again washed five times with EPT. 
Bound mouse antibodies were detected with goat anti-mouse HRP conjugate (Sigma) diluted 
1:1000 in 0.5% BSA-EPT (50 |il, 1 hour at 37°C); rabbit antibodies were detected similarly 
with protein A HRP conjugate. Wells were again washed five times with EPT before 
addition of the detection reagents dissolved in citrate buffer (100 j l l I ) :  0.1M Na2HP0 4 , 
0.08M citric acid pH 4.0.
EPT is 0.15 M NaCl, 7 mM Na2HP04, 3 mM NaH2P 04, 0.05% Tween 20, stored as 
a 10X solution.
Methods
DNA gels:
DNA was electrophoresed through 5% polyacrylamide gels containing 
bis-acrylamide, made up in TBE: 90 mM tris, 89 mM boric acid, 1 mM EDTA. Gels were 
electrophoresed at 100-150 V using TBE as tank buffer, until the dye front was half to two 
thirds of the way to the bottom of the gel.
Mouse immunisation and monoclonal antibody production.
Female balb/c mice were immunised intraperitoneally with solutions of purified UL8 
protein emulsified 1:1 with complete Freund's adjuvant (for the initial injection) or 
incomplete adjuvant (for subsequent injections). 5 or 10 pg of purified protein was used per 
injection. Orbital bleeds were screened for UL8 reactive antibodies by Western blotting. 
One positive mouse was selected, boosted with 35 pg of protein in 10% glycerol, killed 
three days later and its spleen removed.
Sple nocytes were fused at a ratio of approximately 10:1 with Sp2/0 Agl4 balb/c 
mouse myeloma cells using 33% polyethylene glycol, and plated out in 96 well plates in 
Dulbecco's modified Eagle’s medium containing 5-20% foetal calf serum, 1-4% glutamine, 
1% penicillin/streptomycin, 100 pM hypoxanthine, 0.42 pM aminopterin, 63 pM 
thymidine. Colonies were screened at the 24 well plate stage by ELISA. Lines with reactive 
culture supernatants were grown on in the same medium but without hypoxanthine, 
aminopterin, or thymidine and stored in liquid nitrogen.
Ascites fluid was produced by injecting each positive line into mice primed 
intraperitoneally with 0.5 ml of pristane (c.5xl06 cells per mouse). When swelling became 
apparent mice were killed and their peritoneal cavities drained.
ELISA assays.
"kt
ELISA assays were performed in duplicate using Immulon 1 strips or plates. Bound 
antibodies were detected using horseradish peroxidase conjugated to protein A or goat anti­
mouse immunoglobulin. The chromogenic substrate ABTS and hydrogen peroxide were 
employed as detection reagents (used at final concentrations of 0.5 mg/ml and 0.015% 
respectively). These were mixed immediately before use. Optical density at 405 nm was 
read using a Titertek Multiskan Plus plate reader.
Immune precipitations.
The antigen for immune precipitations was a crude extract of Sf cells infected with 
AcUL8 (c.10 pfu per cell) and labelled with 35S methionine from 25-32 hours post infection.
Cells were harvested at 32 hours post infection, lysed in RSB containing 0.5% NP40,
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0.5 mM PMSF, and 1.0 mM DTT, and the extract clarified by centrifugation at 50,000 rpm. 
Approximately 1 x 105 cell equivalents of the labelled extract (20 jllI) were mixed with 1 (il 
of serum or ascites fluid and incubated on ice for 1 hour. (1 ill of sheep anti-mouse 
antibody was added to tubes containing ascites fluid after 40 minutes.) Thirty microlitres of 
immunoprecipitin (suspended, freeze-dried Staphlococcus aureus, Bethesda Research 
Laboratories) was added to the mixture which was then incubated for a further 45 minutes. 
The pellet was centrifuged, separated from the supematent and washed three times with the 
following buffer: 0.1 M Tris pH 8.0, 0.5 M LiCl, 1% P mercaptoethanol. The final pellet 
was dissolved in boiling mix (see 'SDS polyacrylamide gels') and run on a 10% SDS 
polyacrylamide gel.
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RESULTS
The initial aim of this project was to identify the products of the HSV-1 
genes UL5, UL8, UL9, and UL52 by using antisera raised against peptides with sequences 
corresponding to portions of the predicted amino acid sequence of these proteins.
I) SYNTHESIS AND ANALYSIS OF PEPTIDES.
Peptides were synthesised with sequences corresponding to the predicted amino 
acid sequence of parts of the proteins UL5, UL8, UL9, and UL52 (table 1). The regions 
chosen were terminal as termini are generally on the protein's surface. This was intended to 
ensure that in the full protein the epitope recognised by the sera would not be obscured by 
secondary structure. In addition, regions containing amino acid residues that would cause 
problems during peptide deprotection were avoided. For example, peptide 272 omits the 
N-terminal methionine of UL8 as the combination of methionine and tryptophan in a peptide 
can lead to modification of the methionine (Atherton and Sheppard, 1989). The peptides 
were synthesised as single chain peptides for analysis of molecular mass and as 'branched' 
peptides (figure 1, overleaf) to allow the generation of antisera without conjugation to 
carrier proteins.
Table 1. Sequence of peptides and their position in the corresponding protein.
Peptide Sequence Residues of Number of residues
protein in the protein
UL5 238 HILSALRDPNYVIVY 868-882 882
UL8 272 DTADIVWVEES V S AI 2-16 750
UL8 219 KFVYPFDDKMSFLFA 736-750 750
UL9 218 EAWPMMQGAVNFSTL 837-851 851
UL52 220 PCSPSVPCSTSQPSS 1044-1058 1058
Peptides were analysed by three methods. The molecular mass of single chain 
peptides was determined by Fast Atom Bombardment Mass Spectrometry (FAB-MS, by M 
Scan Ltd); the branched peptides were analysed for amino acid composition (by CRB Ltd); 
and both forms of peptide were analysed for purity by reversed phase HPLC.
The measured molecular masses of peptides UL5 238 and UL8 219 agreed exactly 
with the predicted values, (table 2). The value of 1677 rather than 1680 obtained for
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peptide UL9 218 is not easily explained, the difference being too small to correspond to any 
of the species, such as a sodium ion, commonly found associated with peptides. The 
discrepancy may represent a counting error by M-Scan Ltd as the exact Mr of each peak in 
the spectrum was determined manually. The company reported that they were not able to 
maintain peptide UL8 272 in solution under the conditions required for FAB-MS and so no 
data was obtained for this peptide. The spectrum of peptide UL52 220 contained three
Figure 1. Structure of the branched peptides. See Tam (1988).
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Table 2. Molecular mass and approximate purity of peptides. The measured relative 
molecular masses are listed, with the predicted values in parentheses. The measurement is 
accurate to +/- 1.
Peptide Purity by HPLC Mr
Single chain Branched
UL5 238 N .D .a N.D. 1707 (1707)
UL8 272 76% 97% N.D.
UL8 219 60% 91% 1853 (1853)
UL9 218 42% 86% 1677 (1680)
UL52 220 42% 79% 1463b (1462)
a N.D. = not determined.
b Analysis showed three peaks corresponding to molecular masses of 1463, 1519, and 
1635.
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Table 3. Amino acid content of peptides. The quantity of each amino acid observed was 
compared to the expected quantity calculated from the number of residues in the sequence 
and the quantity of peptide hydrolysed. Thus, for example, peptide UL5 238 contained one 
arginine residue and 75% of the expected quantity of arginine was found in the analysis. 
The determination has an error of +/- 15%, and so values from 0.85-1.15 are regarded as 
equal to one. Major deviations from the expected values are discussed in the text.
UL5 238 UL8 272
Peptides 
UL8 219 UL9 218 UL52 220
Alaninea 1.22 (1.12) 2.73 (2.12) 1.41 (1.12) 2.22 (2.12) - (0.12)
Asxb 2.17 (2) 2.03 (2) 2.33 (2) 0.96 (1) -
Arginine 0.75 (1) - - - -
Cysteine - - - - 1.70 (2)
Glxb - 2.33 (2) - 2.04 (2) 1.22 (1)
Glycine - - - 1.00 (1) -
Histidine 0.94 (1) - - - -
Isoleucine 1.69 (2) 1.49 (2) - - -
Leucine 2.11 (2) - 1.02 (1) 1.32 (1) -
Lysinec 1.00 (0.87) 0.89 (0.87) 2.71 (2.87) 0.84 (0.87) 0.91 (0.87)
Methionine - - 0.67 (1) 1.66 (2) -
Phenylalanine - - 3.78 (4) 0.99 (1) -
Proline 1.09 (1) - 1.33 (1) 1.39 (1) 4.27 (4)
Serine 0.89 (1) 1.94 (2) 0.95 (1) 0.66 (1) 3.19 (6)
Threonine - 1.02 (1) - 0.80 (1) 0.88 (1)
Tryptophand - -U ) - -(1) -
Tyrosine 0.98 (1) - 0.82 (1) - -
Valine 1.89 (3) 2.57 (3) 0.99 (1) 1.05 (1) 0.98 (1)
a The structure of the branched peptides causes 0.125 moles of alanine to be present per 
mole of the required sequence, in addition to any alanine in that sequence (see figure 1). 
b The values found against Asx correspond to the amino acids aspartate and asparagine as 
asparagine is hydrolysed to aspartate during the analysis. Glx accounts similarly for 
glutamate and glutamine.
c The structure of the branched peptides causes 0.875 moles of lysine to be present per 
moles of the required sequence, in addition to any lysine in that sequence (see figure 1). 
d Tryptophan is not detected as it is destroyed during hydrolysis.
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peaks corresponding to species with molecular masses of 1463,1519, and 1635. The first 
of these is the molecular ion. The molecular masses of the other species suggest that they 
may be peptides with one or three t-butyl groups still attached, t-butyl groups were present 
as side-chain protectors during the synthesis of the peptide and presumably were not 
removed completely during cleavage. It is not possible to determine the extent of cleavage 
from the FAB-MS results.
Amino acid analysis of peptides UL9 218 and UL8 219 gave results in accordance 
with expectations as did analysis of peptides UL5 238, UL8 272, and UL52 220, with 
the following exceptions (see also table 3). The quantity of isoleucine and valine detected 
in peptides UL5 238 and UL8 272 was low due to incomplete hydrolysis of Ile-Val and 
Val-Val bonds. An anomalously large quantity of alanine seemed to be present in peptide 
UL8 272. Slightly greater than 3 molar equivalents of serine were detected in peptide UL52 
220 rather than the 6 expected. The incomplete deprotection deduced from the molecular 
mass measurement may account for this as t-butyl groups are side-chain protectors for 
serine residues.
Peptides were analysed by reversed phase HPLC and the main peptide peak in the 
chromatogram (recorded at 225 nm) was assumed (on the basis of appropriate amino acid 
analysis and molecular mass data) to be the required sequence. The purity of peptides listed 
in table 2 is the area of the main peak as a percentage of the total area of peaks in the 
chromatogram (see figure 2). Peaks were also scanned over the wavelength range 190-340 
nm to determine if their absorbance profiles were characteristic of peptides. In all cases the 
main peak had the characteristics of a peptide. That is, the absorbance peaked around 195 
nm with a subsidiary peak at 280 nm if the peptide contained aromatic residues. The main 
impurities in the peptides run very close to the main peak and also have an absorbance 
profile characteristic of peptides. These probably represent species having one amino acid 
more or less than the required sequence. In branched peptides these alternative sequences 
will often form part of the same molecule and therefore will not be resolved by HPLC. 
Therefore purity is assessed better on single chain peptides. No data were obtained for 
peptide UL5 238 as it could not be dissolved in solvents suitable for chromatography. 
However amino acid analysis and Mr measurement suggest that the sample contains 
principally the correct sequence. Inclusion of peaks probably due to t-butyl containing 
species in the calculation of the purity of peptide UL52 220 raises the value obtained to 
69%. Based on the three analyses, the purity of all peptides was judged suitable for the 
production of antisera.
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Figure 2. Chromatography of peptides by reversed phase HPLC using a Dynamax Cg 
column. Absorbance at 225 nm is plotted versus elution time in minutes. In each case the 
main peak is due to the required peptide. A) peptide UL9 218 single chain; B) peptide 
UL8 219 single chain; C) peptide UL52 220 single chain; D) peptide UL8 272 single 
chain.
A)
B)
co
II) PRODUCTION OF ANTIPEPTIDE ANTISERA.
Results
Emulsified solutions of branched peptides were injected into rabbits and the 
resulting sera were tested on Western blots against extracts of cells infected with the 
recombinant baculoviruses AcUL5, AcUL8, AcUL9, and AcUL52 (Calder and Stow, 
1990; Stow, 1992), which express the named protein. The results are shown in figure 3 
and summarised in table 4.
Table 4. Titre of antipeptide sera on Western blots. The titre is defined as the greatest 
dilution of the serum that produced a visible band.
Peptide Number of 
reactive seraa
A pproxim ate
Titre
Serum num ber
UL5 238 0(2) - _
UL8 272 2(2) both 1:300 063, 064
UL8 219 2(2) 1:64,1:250 007, 008
UL9 218 1(6) 1:64 021
UL52 220 0(3) - -
a The values in parentheses are the number of rabbits used in attempts to produce positive 
sera.
Attempts to produce antipeptide sera reactive with proteins UL5 and UL52 were not 
successful. One serum reacting with protein UL9 was produced (serum 021; figure 3B). 
Pre-immune serum from rabbit 021 did not recognise proteins in cell extracts containing 
UL9, and the immune serum did not react with extracts of cells infected with wild type 
AcNPV. High titre sera recognising both the N- and C-termini of UL8 were produced. 
That they are UL8 specific is shown in figure 3A. The protein recognised by these sera 
corresponds to a protein seen in SDS polyacrylamide gels that is specific for AcUL8- 
infected cells.
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Figure 3. Reactivity of antipeptide sera on Western blots. A) Extracts of cells infected with 
AcUL8 or wild type baculovirus (AcNPV) were electrophoresed on 10% SDS 
polyacrylamide gels, transferred to nitrocellulose, and immunoblotted with antipeptide sera. 
The figure shows the reactivities of the pre-immune (PI) and immune (I) sera from rabbits 
064 (N-terminus reactive) and 008 (C-terminus reactive), both used at a dilution of 1:200. 
Similar results were obtained with sera 007 and 063. B) Western blot using an extract of 
cells infected with AcUL9 as antigen. Sera used were: lane 1: positive control (anti-UL9 
serum at 1:50 dilution, gift of M.D. Challberg, National Institutes of Health; USA); lane 2: 
buffer only; lanes 3-6: serum 021 at dilutions 1:4,1:16,1:64, and 1:256 respectively.
wtAcNPV AcUL8
N C N C
I PI I PI I PI I PI
A *
1 2 3  4 5  6
Results
III) PURIFICATION OF UL8.
As UL5, UL9, and UL52 began to be examined by other workers but the function 
of UL8 remained unknown, this project focused more closely on purifying and 
characterising UL8. This* choice was supported by the fact that the best sera produced 
were those reacting with UL8.
Production of crude cell extract
To overcome the difficulties caused by the tiny quantities of UL8 present in HSV-1 
infected cells, UL8 protein was purified from Spodoptera frugiperda (Sf) cells infected with 
the recombinant baculovirus AcUL8 (Calder and Stow, 1990). UL8 expressed in Sf cells 
appears to be identical to that produced in HSV-1 infected cells as it is able to support the 
replication of a transfected plasmid containing an HSV-1 origin of replication (Stow, 1992).
Initial experiments focused on producing a crude extract containing UL8 in a stable, 
soluble form. UL8 expressed in Sf cells can be extracted in the soluble cytoplasmic fraction 
(Calder and Stow, 1990). In initial attempts to produce a crude extract Sf cells expressing 
UL8 were lysed in T buffer (10 mM triethanolamine pH 7.5 (HC1), 10 mM KC1, 1.5 mM 
MgCl2, 1 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 10 tig/ml leupeptin, 
10 fig/ml pepstatin A) using a Dounce homogeniser. The extract was centrifuged at 
10,000g for 30 seconds to pellet nuclei and the supernatant clarified by centrifugation at 
175,000g for 30 minutes at 4 °C. It became apparent that due to the use of small sample 
volumes, losses in the homogeniser were large and so this was abandoned in favour of 
using the detergent NP40 at a concentration of 0.5% (v/v) to lyse the cells. This 
modification resulted in most UL8 being detected in the supernatant fraction after 
centrifugation (figure 4A), provided the cells were resuspended in the buffer before the 
detergent was added. If buffer containing detergent was added to the cell pellet the cells 
could not be resuspended. The presence of UL8 in the supernatant was confirmed by 
Western blotting.
The stability of UL8 in the crude extract was investigated. Portions of the crude 
extract were incubated at 25 °C or 4 °C, subjected to a number of cycles of freezing and 
thawing or diluted two, four, or eight-fold. Portions were centrifuged at 10,000g for 10 
minutes at 4 °C at each stage to pellet denatured protein and part of the supernatant was 
electrophoresed on a protein gel (figure 4B). The results show that UL8 remained in the 
supernatant after all these treatments and therefore was probably not denatured. The 
stability experiments also show that no substantial proteolysis was occurring in three and a 
half hours at room temperature under these conditions. Initial attempts to identify suitable 
chromatography matrices for purification of the UL8 protein were thwarted by the 
observation that addition of the crude extract to any of the matrices investigated caused most
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Figure 4. Initial experiments on the solubility and stability of the UL8 protein.
A) Soluble and insoluble material obtained after extraction of S. frugiperda cells with T 
buffer containing NP40. Portions of the supernatant (lane 1) and the pellet (lane 2) from 
low speed centrifugation were dissolved in gel sample buffer and run on a 10% SDS 
polyacryamide gel. Proteins were visualised with Coomassie Blue. UL8 is indicated by the 
arrow.
B) Stability of UL8 undergoing various treatments. The position of UL8 on both gels is 
indicated by the arrows. Incubation at 25 °C: lanes 1-5 show the crude extract at the start of 
the experiment and after 1, 2, 3, and 3V2 hours incubation respectively. Lane 6 shows the 
pelllet from the final sample. Similarly, lanes 7-12 show the results of incubation at 4 °C 
for these times. Lane M is a marker track (untreated material). Lanes 13-17 show the 
effects of freezing and thawing. Lane 13: starting material; lane 14: blank; lane 15: frozen 
and thawed twice; lane 16: frozen an d thawed three times; lane 17: pellet from the final 
sample. Lanes 18-20 show the effects of dilution with the initial extraction buffer (T 
buffer). Lane 18: starting material; lane 19: diluted two-fold; lane 20: diluted four-fold; lane 
21: diluted eight-fold; lane 22: pellet.
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Results
of the UL8 protein to precipitate in the column. This problem was eventually solved by the 
inclusion of 10% glycerol in the harvesting buffer and all chromatography buffers.
Fractionation of the crude extract. 
i) Precipitation with ammonium sulfate.
A crude extract of proteins in T buffer was precipitated with ammonium sulfate. 
Concentrations of 0, 25%, 40%, 60% and 80% saturating ammonium sulfate were initially 
tested. Portions of each supernatant and pellet were electrophoresed on SDS poly­
acrylamide gels and Western blotted. The results of the experiment are shown in figure 5A. 
The experiment shows that UL8 precipitates slightly at 25% salt and totally at 40% or 
higher concentrations. The amount of salt required to precipitate UL8 was refined using 
28%, 32%, 36%, and 40% saturating salt concentrations (fig 5B) until an optimal value of 
36% was determined that gave maximum UL8 precipitation with minimum precipitation of 
other proteins. The purification achieved was excellent as UL8 precipitated at such a low 
salt concentration. Not all UL8 is precipitated by 28% or 32% saturating ammonium 
sulfate, but the protein is not found in the supernatant fraction of samples treated with these 
concentrations of salt. The reason for this is not clear, but may involve a salt activated 
protease.
Despite the substantial purification achieved with ammonium sulfate fractionation, 
this technique could not be used as UL8 protein appeared to be irreversibly denatured by it. 
While the precipitated protein could be resuspended in SDS containing buffer for gel 
electrophoresis, no non-denaturing buffer was able to resuspend it. Buffers used included 
RSB and RSB containing 0.05% NP40 or 10% glycerol.
ii) Anion exchange chromatography: MonoQ column.
Ion exchange chromatography was investigated as a purification method. To 
determine if a cation or an anion exchanger should be used, two attempts were made to 
determine the isoelectric point of UL8. A chromatofocusing column from Pharmacia was 
used, run from pH 1 to pH 4. The vast majority of the UL8 loaded was lost on the column 
and the small amount of UL8 that eluted formed a very broad peak eluting between pH  5.0 
and 4.5. However as UL8 bound to the column its isoelectric point was clearly less than 
pH 1 and an anion exchanger was selected. (The calculated isoelectric point of UL8 is 
approximately 5.8.)
Initial experiments used a 1 ml MonoQ anion exchange column. The column was 
equilibrated in 20 mM triethanolamine buffer pH 7.5 and a crude cell extract was added. 
The column was washed with the same buffer, and bound proteins were eluted with a 
gradient from the starting buffer to 20 mM triethanolamine 1 M NaCl pH 7.5. UL8 eluted
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Figure 5A. Ammonium sulfate precipitation of UL8 protein.
I) Crude cell extract containing UL8 was fractionated with 25%, 40%, 60%, or 80% 
saturating ammonium sulfate as indicated and portions of the supernatant (SN) and pellet 
(P) fractions were electrophoresed on SDS polyacrylamide gels. Proteins were detected by 
Coomassie blue staining. The lane marked S contains the starting material.
II) Crude cell extract containing UL8 was fractionated with 0, 25%, 40%, or 60% 
saturating ammonium sulfate as indicated and portions of the supernatant (SN) and pellet 
(P) fractions were electrophoresed on SDS polyacrylamide gels and immunoblotted with 
serum 008 at 1:200 dilution.
I)
II)
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Figure 5B. Ammonium sulfate precipitation of UL8 protein -  fine cuts.
I) UL8 was precipitated with 28%, 32%, 36%, or 40% saturating ammonium sulfate and 
the supernatant (SN) and pellet (P) from each fractionation were electrophoresed on 10% 
SDS polyacrylamide gels. The lane marked S contains the starting material. Proteins were 
detected by Coomassie blue staining.
II) Proteins were precipitated with 28%, 32%, 36%, or 40% saturating ammonium sulfate 
and electrophoresed on SDS gels. UL8 in supernatants (SN) and pellets (P) was detected 
by immunoblotting with serum 008 at 1:200 dilution. The lane marked S contains the 
starting material.
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at<c.0.3 M NaCl in 3 ml of buffer. Considerable purification was achieved, although 
recovery was low (c. 50 %). (Fig 6).
Increasing the concentration of triethanolamine to 40 mM to improve buffering and 
the inclusion of 10% glycerol or 0.5% NP40 in the starting and elution buffers did not 
improve the yield. The use of buffers at pH 6.5 or 6.1 to run the column also did not 
improve the yield and a lower pH could not be used to titrate the protein closer to neutrality 
as UL8 is not stable at such low pHs. There was no reason to try a buffer of higher pH as 
this would only increase any negative charge on the protein and so the pH required to 
reduce the charge of the column substituents and thus their affinity for the protein would be 
unreasonably high.
One attempt was made to bind the UL8 protein to a MonoS cation exchange column 
in 50 mM HEPES buffer pH 7.5. However under these conditions most UL8 passed 
straight through the column without interacting with the matrix. As many other proteins 
also did not bind to the column, little purification was achieved and this approach was not 
pursued.
iii) Fractionation using a phenyl superose column.
Hydrophobic interaction chromatography was investigated as a method of 
purification. Crude extracts of Sf cells expressing UL8 were added to a phenyl superose 
column equilibrated in 20 mM triethanolamine pH 7.5, 0.5 M NaCl and the column was 
developed with a gradient to 20 mM triethanolamine pH 7.5, 2% glycerol. In initial 
experiments the loading buffer contained 2 M NaCl but the use of this concentration of salt 
was found to be unnecessary. The majority of the proteins eluted in the flow through but 
UL8 eluted, considerably purified, at the end of the gradient (figure 7). Recovery was 
approximately 50% in this experiment but was unpredictable in later experiments due to 
variations between different crude extract preparations.
Several other chromatography matrices were tested for use in purifying UL8 but 
none proved suitable. UL8 either failed to bind to the matrix or could not be eluted without 
being denatured. The matrices tested were: heparin affigel; DE52 anion exchanger; cibacron 
blue 3GA-agarose; CTP agarose; blue dextran agarose; reactive red 120 agarose. Attempts 
to use hydroxy apatite were also unsuccessful. The matrix bound UL8 and the protein 
could be eluted to some extent, but the flow characteristics of the matrix were very poor.
Two purification steps had now been developed although each was of only 
moderate yield. The effectiveness of the steps varied between different preparatioifof crude 
extract, probably due to variations in total protein concentration, a factor which seemed to 
affect the stability of UL8 in the harvesting buffer (T buffer).
71
Figure 6. MonoQ fractionation of crude extract containing UL8. A Coomassie blue stained 
gel of the crude extract (CE) loaded onto the column and fractions 16-19. Fraction size was 
1.5 ml. Western blotting showed that these fractions were the only ones in  which JXJL8 
See the text for experimental details. was detected, ,
Figure 7. A Coomassie blue stained gel of crude cell extract (CE) chromatographed on a 
phenyl superose column and of the fractions eluted from the column. Fractions 2 and 3 are 
the flow through and fractions 23 to 28 are the only ones containing UL8, again 
demonstrated by Western blotting. Fractions were 1 ml.
CE 16 17 18 19
CE 2 3 23 24 25 26 27 28
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iv) Fractionation using diethylaminoethyl (DEAE) sepharose.
At this stage in the work the publication of a method for the purification of UL8 
(Dodson and Lehman, 1991) suggested some changes to the purification scheme. The 
method of Dodson and Lehman used heparin agarose, DEAE sepharose, hydroxyapatite, 
and gel filtration columns. Ten per cent glycerol was used in all buffers except the 
harvesting buffer, presumably to increase the stability of the protein.
A DEAE sepharose column was packed and equilibrated in 20 mM triethanolamine 
pH 7.5, 10% glycerol, 0.1 M NaCl. Crude extract harvested in T buffer was loaded, the 
column washed with the start buffer, and the proteins eluted with a gradient from 0.1 M to 
0.5 M NaCl in 20 mM tris pH 8.0, 10% glycerol. UL8 protein eluted around 0.3 M 
NaCl but yields were still low, comparable to those achieved with the MonoQ column. 
This was unexpected as the published method had achieved a high yield. The experiment 
was repeated using crude extract harvested in a buffer containing 10% glycerol, G buffer: 
20 mM triethanolamine pH 7.5 (HC1), 10% glycerol, 10 mM KC1, 1.5 mM MgCl2, 0.5% 
NP40, 1 mM DTT, 0.5 mM PMSF, 10 |ig/ml leupeptin, 10 pg/ml pepstatin A. This 
modification gave an approximately quantitative yield (figures 8 & 9 A).
v) Fractionation using phenyl sepharose.
Due to an observed progressive deterioration in the chromatographic properties of 
the phenyl superose column, hydrophobic interaction chromatography was continued with a 
phenyl sepharose matrix. The inclusion of 10% glycerol in the buffers for this matrix also 
improved the yield of UL8 obtained. Initial experiments with loose matrix in an eppendorf 
tube suggested that UL8 would bind and could be eluted from the matrix by buffers 
containing NP40. Use of a column however showed that water at 4 °C containing 10% 
glycerol was sufficient to elute the protein. Therefore the fractions from the DEAE 
sepharose column that contained UL8 were pooled and loaded without further treatment 
onto a phenyl sepharose column equilibrated in 20 mM tris pH 8.0 (HC1), 10% glycerol, 
0.1 M NaCl. The column was washed with the starting buffer and a gradient to 10% 
glycerol in water at 4 °C was applied. UL8 eluted, virtually pure, at the end of the gradient 
(figures 8 & 9A). A nearly quantitative recovery of UL8 protein was achieved. Scanning 
of a Coomassie blue stained SDS polyacrylamide gel of the peak fractions showed that UL8 
purified through DEAE sepharose and phenyl sepharose columns in the manner described 
produced protein that was 95% pure.
Western blotting of purified UL8 with N and C terminal antisera showed that the 
protein was intact and that no degradation products were present (fig 9B). The purified 
protein was probably not denatured as centrifugation at 10,000g did not precipitate it.
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Figure 8. UV absorbance of material eluting from DEAE sepharose (upper panel) and 
phenyl sepharose columns (lower panel). Optical density at 280 nm is plotted versus 
elution volume in ml. Fractions containing UL8 are those between the arrows. The 
absorbances recorded are from an experiment using 4 ml of crude extract as starting 
material. Fractions from the DEAE column which contained UL8 were loaded onto the 
phenyl sepharose column.
Figure 9. A) Proteins present at different stages of the purification procedure, visualised 
by Coomassie staining of a 10% SDS polyacrylamide gel. The position of the UL8 protein 
is shown by the arrow. The five tracks show the proteins in the crude extract (CE) and the 
proteins that flowed through (FT) the DEAE sepharose (DEAE) or phenyl sepharose 
(PHENYL) columns or that eluted in the peak fractions (PK). The fractions from the 
DEAE column that contained UL8 were pooled and added to the phenyl sepharose 
column. B) Recognition of purified UL8 protein by antisera reacting with the N and C 
termini of the protein (sera 064 and 008). This panel shows a Western blot of proteins 
transferred from a 10% SDS gel.
DEAE PHEN 
CE FT PK FT PK
_ _
B) N C
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A summary of the full purification scheme, as used to produce the protein used for 
the rest of the experiments described in this thesis, is included in the methods section.
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IV) PROPERTIES OF UL8.
i) Structure of UL8 protein in solution.
In HSV-1 infected cells UL8 protein exists as part of a 1:1:1 complex with the UL5 
and UL52 proteins. The complex has a molecular mass of 263,000 daltons (Crute and 
Lehman, 1991). Whether purified UL8 was a monomer in solution or formed a complex 
was determined using gel filtration chromatography. UL8 eluted from a gel filtration 
column between 11.7 ml and 12.8 ml with a peak at 12.3 ml (see figure 10) giving an 
estimated molecular mass of 75,000 +/- 10,000 daltons. While this is an imprecise 
molecular mass determination the result shows unambiguously that purified UL8 exists as a 
monomer in solution.
ii) Investigations of possible interactions of UL8 protein with nucleic acids.
UL8 has an important role in nuclear localisation of the helicase primase complex of 
HSV-1 (Calder et al, 1992) but this is unlikely to be its only function. In searching for 
additional functions of UL8, its interaction with nucleic acids was investigated using a DNA 
band shift assay. As part of the viral helicase-primase complex UL8 has the opportunity to 
interact with a number of different nucleic acids: double stranded DNA; single stranded 
DNA; partially double stranded DNA; and DNA/RNA hybrids. Binding of UL8 to all 
these nucleic acids was examined.
Double stranded DNA.
Figure 11A shows the results of incubating UL8 with double stranded DNA. In 
contrast to UL42, up to 60 ng of UL8 in the reaction has no effect on the mobility of the 
probe after an incubation at 37 °C in low salt GRA buffer (50 mM HEPES pH  7.8 (NaOH), 
10% glycerol, 0.1 mM EDTA, 0.5 mM DTT) (lanes 2-4). Experiments using up to 
600 ng of UL8 also showed no effect of UL8 on probe mobility, nor did experiments 
carried out in GRA buffer (50 mM HEPES pH 7.8 (NaOH), 10% glycerol, 50 mM NaCl, 5 
mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT) or experiments carried out at room temperature 
or 4 °C. A number of different preparations of UL8 were used. Similar experiments 
performed with partially duplex DNA also failed to reveal any binding of UL8 (figure 11B).
Single stranded DNA.
Figure 12A shows the results of a band shift experiment using a single stranded 
DNA probe. As can be seen, addition of up to 600 ng of UL8 causes no shift in the 
position of the probe relative to reactions containing only water or buffer. Inclusion in the 
reaction mixture of gene 32 protein of T4 bacteriophage which binds cooperatively to single
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Figure 10. UL8 molecular mass determination. The elution of purified UL8 from a gel 
filtration column is shown (peak) together with the positions of elution of molecular 
weight standards (circles). Proteins used as molecular mass standards were: (3-amylase 
(Mr 200,000); alcohol dehydrogenase (Mr 150,000); bovine serum albumin (Mr 66,000); 
and carbonic anhydrase (Mr 29,000). The straight line is a best fit line for the four points 
drawn by computer.
Figure 11. DNA mobility shift of double stranded DNA (A, lanes 1-6) or partially double 
stranded DNA (B, lanes 7-12). All reactions contained 1 ng of the appropriate nucleic 
acid.
A) Lane 1 shows the position of the complex (arrow) formed by duplex oligonucleotide 
and 170 ng of purified HSV-1 UL42 protein. The free probe is seen in lane 6 which had 
only water added to the binding reaction and in lane 5 which had only the buffer used to 
dilute UL8 protein added to the reaction mixture. 60, 6, or 2 ng of UL8 were added to the 
reactions shown in lanes 2-4.
B) Labels are as for panel A except for the quantities of UL8 added to the reaction. Also, 
only 0.25 ng of UL42 was used in the postive control reaction (lane 7).
A) 42 UL8 B W 
60 6 2 ng
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Figure 12. DNA mobility shift of single stranded DNA (A, lanes 1-5) or a DNA/RNA 
hybrid (B, lanes 6-11). All reactions contained 1 ng of the appropriate nucleic acid.
A) Reactions mixtures contained: 8500 ng of bacteriophage T4 gene 32 protein (lane 1); 
600 or 60 ng of purified UL8 (lanes 2 and 3 respectively); UL8 dilution buffer (lane 4); or 
water (lane 5). The arrow indicates the position of the complex formed between gene 32 
protein and the probe.
B) One unit of bacteriophage T7 RNA polymerase (lane 6); 600, 180, 60 or 18 ng of 
purified UL8 protein (lanes 7-10); or water (lane 11) was added to the basic reaction 
mixture. The complex formed by T7 RNA polymerase is indicated by the arrow.
A) 32 UL8 
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stranded DNA causes the probe (arrow) to run just below the position of the gel loading 
slot. This experiment was performed in GRA buffer at 37 °C and similar experiments 
performed in low salt GRA buffer or at 25 °C or 4 °C produced identical results.
DNA/RNA hybrid.
Possible interaction of UL8 with a DNA/RNA hybrid [polyCrAj.oligoCdT)^.^] was 
investigated. The results are shown in figure 12B. No specific band due to UL8 can be 
seen although T7 RNA polymerase binds to the probe under the reaction conditions 
(arrow). The experiment shown in figure 12B was performed in low salt GRA buffer at 
37 °C, however further experiments at different temperatures or in GRA buffer also failed 
to detect binding of UL8 to the probe.
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V) PRODUCTION OF MONOCLONAL ANTIBODIES.
Purified UL8 protein was used to immunise mice to produce monoclonal antibodies. 
It was necessary to test conditions for screening hybridoma supernatants by ELISA against 
purified UL8 and to find a suitable positive control.
i) Development of ELISA screen for hybridoma supernatants.
Only antipeptide sera reactive to UL8 protein were available as a positive control in 
the initial stages of the development of an ELISA screen. ELISA assays were performed to 
test sera 008 and 064, using a crude extract of Sf cells as antigen. The results obtained with 
antiserum 008 are shown in figure 13. Optical density falls off as expected with increasing 
dilution of the antiserum. However, the optical density readings were inversely 
proportional to antigen concentration. Due to this unexpected result a greater range of 
antigen concentrations was investigated. (As virtually identical results were obtained with 
serum 064, experiments were continued with serum 008 alone.) In the second experiment 
(figure 14) the same range of antiserum dilutions were used but the quantity of antigen 
covered a greater range. It is clearly seen that there is a drop in absorbance with
antiserum dilution and that the highest absorbance was seen with approximately 100 ng of 
UL8 per well. The drop in absorbance at higher antigen concentrations is presumably due 
to some interfering compound in the cell extract. The observed absorbance was sufficient 
for the ELISA screen and no further experiments were performed to determine the quantity 
of UL8 required for maximum absorbance. It should be noted that the quantity of UL8 
used as antigen is an estimate. The estimate is based on the total protein concentration of 
the extract (measured using a commercial assay kit) and the proportion of the proteins 
thought to be UL8 from examination of Coomassie stained gels. For example, the total 
concentration of proteins in crude extracts was usually of the order of 4 mg/ml and UL8 
comprised approximately 5% of the cell protein. The optical density of all these ELISA 
assays was measured after half an hour. A linear increase in optical density with time was 
observed in all cases.
Five mice were immunised with purified UL8 protein. Sera from these mice were 
tested on Western blots (figure 15). Serum from mouse 3 had the strongest and cleanest 
anti-UL8 reactivity, and so this mouse was chosen for use in the fusion. Serum from 
mouse 3 was tested for use as a positive control in ELISAs. Purified UL8 was used as 
antigen (figure 16). This shows that a strong reaction can be obtained even at a dilution of 
102,400 with a UL8 concentration of 100 ng per well. In general, for use as a positive 
control, the serum was diluted 10,000 fold.
As a result of this experiment hybridoma supernatants were screened using 1 (ig or 
400 ng of purified UL8 per well, \  / Optical
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Figure 13. Results of ELISA assays of serum 008 tested against a crude extract of cells 
containing UL8. A) Optical density at 405 nm is plotted versus estimated quantity of UL8 
protein per well for a number of serum dilutions, as given next to the figure. B) Optical 
density at 405 nm is plotted versus serum dilution for a number of quantities of antigen. 
These are given in the figure in ng per well.
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Figure 14. Results of ELISA assays of serum 008 tested against a crude extract of cells 
containing UL8. A) Optical density at 405 nm is plotted versus estimated quantity of UL8 
protein per well for a number of serum dilutions, as given in the figure. B) Optical density 
at 405 nm is plotted against serum dilution for a number of quantities of antigen. These are 
given in the figure in ng per well.
Figure 15. Western blot of sera from mice immunised with purified UL8 protein. Each 
serum (1-5 as indicated) were screened at dilutions 1:100; 1:500; and 1:2000. These are 
shown successively from left to right for each serum. '+' indicates the positive control 
which was serum 008 used at a dilution of 1:200.
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Figure 16. Results of ELISA assays of serum from mouse 3 tested against purified UL8. 
A) Optical density at 405 nm is plotted against quantity of UL8 protein per well for a 
number of serum dilutions, as given in the Figure. B) Optical density at 405 nm is plotted 
against serum dilution for a number of quantities of antigen per well. These are given in 
the Figure.
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density readings of > 0.4 after 15 minutes were regarded as positive. All blanks were of 
negligible absorbance (< 0.05).
ii) Production of monoclonal antibodies and ascites fluid.
Sple nocytes from mouse 3 were fused to produce hybridoma lines. Eighty one 
hybridoma lines were produced of which 25 (31%) were positive when assayed by ELISA 
versus purified UL8 protein in the initial screen. Twenty of the positive lines continued to 
make UL8-specific antibody until they could be injected into mice to produce ascitic fluid. 
Nineteen of the resulting ascitic fluids were positive by ELISA against UL8.
iii) Characterisation of monoclonal antibodies.
The monoclonal antibodies produced were characterised by testing whether they 
reacted with UL8 protein in immune precipitations and Western blotting. Representative 
results are shown in figure 17 and summarised in table 5. Twelve of the ascitic fluids were 
tested in Western blots and immune precipitations; 7 of those tested were positive in 
Western blotting and 6 reacted with UL8 in immune precipitations. Western blot titres of the 
positive ascitic fluids varied from 103 to 105. As can be seen in figure 17 some UL8 is 
precipitated in the control lane. For this reason it is not possible to distinguish between 
antibodies reacting weakly in immune precipitations and those that do not react at all. 
Therefore only strongly reacting antibodies are regarded as positive.
iv) Rabbit anti-protein sera.
Two rabbits were injected with purified UL8. The resulting sera (094 and 105) 
reacted specifically with UL8 in Western blots at dilutions of 1:4000 and also precipitated 
UL8 from solution (figure 17).
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Figure 17. A) Western blot of ascites fluids and rabbit sera. An extract of Spodoptera 
cells expressing UL8 was used as antigen. The positive control (+) is serum 008 at 1:200 
dilution; the negative control (-) is buffer. The reactivity of ascites fluids 809, 813, and 
811 at 103, 104, and 105-fold dilution is shown. Reactivity of rabbit sera 094 and 105 at 
1000, 2000, and 4000-fold dilution is shown.
B) An autoradiograph showing immune precipitation of 35S-labelled UL8 (arrow) by 
polyclonal and monoclonal antibodies specific for the protein. Lanes 1 and 2 show 
precipitation by sera from rabbits 094 and 105 respectively. Lanes 3-15 correspond to the 
following ascites fluids: 3: MP0809; 4: MP0810; 5:MP0811; 6: MP0812; 7: MP0813; 
8: MP0814; 9: MP0815; 10: MP0816; 11: MP0817; 12: MP0818; 13: MP0819; 
14: MP0820; 15: control ascites. The starting material is electrophoresed in the lane 
marked st.
A more accurate reproduction of the original autoradiograph may be found in the pocket at 
the back of the thesis.
A) 809 813 811 094
+ - 3 4 5  3 4 5  3 4 5 1 2 4
M *
B)
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Table 5. Anti-UL8 monoclonal antibodies. The reactivity of each ascites fluid in ELISA, 
Western blot and immune precipitation is shown (+/-) with approximate titres given in 
parentheses for those testing positive in Western blot. The titre is defined as the greatest 
dilution of the ascitic fluid that produced a visible band. N.D. indicates not determined.
Cell line Ascites positive by:
ELISA W estern
blot
Immune
precipitation
MP0801 + N.D. N.D.
MP0802 + N.D. N.D.
MP0803 + N.D. N.D.
MP0804 + N.D. N.D.
MP0805 + N.D. N.D.
MP0806 + N.D. N.D.
MP0807 + N.D. N.D.
MP0808 - N.D. N.D.
MP0809 + + (105) -
MP0810 + - -
MP0811 + + (103) +
MP0812 + + (104) -
MP0813 + - +
MP0814 + + (104) -
MP0815 + - -
MP0816 + - -
MP0817 + + (104) +
MP0818 + + (104) +
MP0819 + + (104) +
MP0820 + _ +
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The initial aim of this project was to identify the products of the HSV-1 open 
reading frames UL5, UL8, UL9, and UL52 which were known to be involved in viral 
DNA replication but were otherwise uncharacterised. Subsequently, as UL5, UL9, and 
UL52 were examined by other workers but the function of UL8 remained unknown, the 
project focused more closely on purifying and characterising UL8. Development of 
reagents to aid detailed analysis of UL8 was another aim. These aims were achieved.
Peptides and antipeptide sera.
Peptides have been synthesised with sequences corresponding to parts of the 
predicted sequences of proteins UL5, UL8, UL9, and UL52. Analysis of these peptides by 
HPLC, FAB-MS spectrometry, and amino acid analysis showed that they were sufficiently 
pure to use for generating antisera. Branched peptides were used to produce antisera as 
generally they are more antigenic than peptides conjugated to carrier proteins (McLean et 
al, 1991). Also they do not require conjugation to a carrier protein. Antisera raised 
against these peptides recognised two of the corresponding proteins, UL8 and UL9, at 
dilutions from 1:64 to 1:300. It is noteworthy that these sera confirm the accuracy of the 
HSV-1 predicted amino acid sequence in these regions (McGeoch et al, 1988a), including 
the minimum length of the coding region designated as gene UL8. The availability of sera 
recognising UL8 allowed the purification of that protein. Repeated attempts to raise sera 
recognising the proteins UL5 and UL52 in Western blots were unsuccessful. This is 
somewhat surprising as Olivo et al (1989) raised sera recognising proteins UL5 and UL52 
on Western blots using peptides corresponding to the same part of the protein. For UL5 
residues 874-882, and for UL52 residues 1051-1058 (compare with table 1 of the results). 
Thus these sequences do not appear to be inherently of low immunogenicity, nor are the 
epitopes of the proteins resistant to exposure even during denaturation. Olivo et al used 
peptides coupled to keyhole limpet hemocyanin rather than branched peptides. However, 
as noted above, branched peptides are generally more antigenic than peptides conjugated 
to carrier proteins (McLean et al, 1991). As the anti-peptide titres of the sera were not 
measured it is not jknown ■ whether the peptide synthesis and purification, the
immunisation or the screening of the sera was at fault.
Purification of UL8 protein.
A procedure for purifying the HSV-1 UL8 protein was developed. The purification 
is simple, requiring only two chromatography columns (DEAE and phenyl sepharose), and 
may be completed in 3V2 hours beginning with the crude extract. The purified protein is
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greater than 95% pure and a yield of 1.5 mg of protein is obtained from 2.4 x 108 cells, 
equivalent to eight 175 cm2 tissue culture flasks. The protein is not significantly 
proteolysed and is probably not denatured. The DEAE sepharose step is very similar to 
one step of a four column purification (heparin agarose, DEAE sepharose, hydroxyapatite, 
and gel filtration) described by Dodson and Lehman (1991). UL8 protein purified by 
Dodson and Lehman (1991) was described as greater than 95% pure although no data were 
presented. Those workers obtained approximately half the yield reported here. In addition 
my two step purification is likely to be simpler and faster. A partial purification producing 
UL8 30% pure, was reported by Sherman et al (1992). This purification was from cells 
expressing UL5, UL8, and UL52 so that the UL8 produced might contain other 
components of the helicase primase complex, an obvious disadvantage.
Initial experiments demonstrated that UL8 was stable in the harvesting buffer then 
being used (T buffer). The protein was stable while standing at 25 °C or 4 °C and was also 
stable to freezing and thawing and dilution. It was not possible to assay for activity but the 
protein was not denatured or significantly proteolysed during these treatments. Initial 
attempts to purify the protein showed that it was less resilient than it had seemed. 
Experiments using ammonium sulfate precipitation as a method of purification were 
unproductive as UL8 is denatured by this salt. In addition, interaction of the protein with 
all matrices tested resulted in large losses and the behaviour of the protein was 
unpredictable, varying from preparation to preparation. The stability of UL8 may be 
dependent on the total concentration of proteins in the preparation. The inclusion of 
glycerol at 10% by volume in the harvesting buffer and all chromatography buffers 
reduced losses of UL8 to undetectable levels. The value of glycerol in stabilising proteins 
in solution is well established (Scopes, 1982).
Conclusions may be drawn about the surface of UL8 from its chromatographic 
properties. The behaviour of UL8 in anion exchange chromatography suggests that it has a 
surface that is strongly negatively charged or with one region which is strongly negatively 
charged. UL8 bound very firmly to mono Q columns (substituted with quaternary 
ammonium groups) and to a diethyl amino ethyl-substituted matrix (DEAE sepharose). 
This interaction is presumably mediated by the side chains of aspartate or glutamate 
residues. Examination of the predicted sequence of the protein shows that acidic residues 
are not concentrated in any region of the protein (see overleaf). While the primary 
structure of the protein says little about the distribution of charges in the three dimensional 
structure, the distribution suggests that the binding is probably due to the overall negative 
charge of the surface. Elution of the protein from DEAE sepharose by a combination of 
increasing sodium chloride concentration and pH was probably due to disruption of salt 
bridges by the sodium chloride ions but also due to titration of column substituents closer 
to neutrality, as DEAE matrices do titrate in the region pH 7.5 -  8.0 (Scopes, 1982). As 
UL8 did not bind to the ciion exchange column mono S, there is presumably no region of
80
The primary structure of UL8 protein of HSV-1 (750 amino acids). Overleaf is a plot of 
the physicochemical characteristics of the amino acids of UL8 against their position in the 
protein. This plot was compiled using the University of Wisconsin Genetics Computer 
Group software.
1 MDTADIVWVE ESVSAITLYA VWLPPRAREY FHALVYFVCR NAAGEGRARF
51 AEVSVTATEL RDFYGSADVS VQAWAAARA ATTPAASPLE PLENPTLWRA
101 LYACVLAALE RQTGPVALFA PLRIGSDPRT GLVVKVERAS WGPPAAPRAA
151 LLVAEANIDI DPMALAARVA EHPDARLAWA RLAAIRDTPQ CASAASLTVN
201 ITTGTALFAR EYQTLAFPPI KKEGAFGDLV EVCEVGLRPR GHPQRVTARV
251 LLPRDYDYFV SAGEKFSAPA LVALFRQWHT TVHAAPGALA PVFAFLGPEF
301 EVRGGPVPYF AVLGFPGWPT FTVPATAESA RDLVRGAAAA YAALLGAWPA
351 VGARWLPPR AWPGVASAAA GCLLPAVREA VARWHPATKI IQLLDPPAAV
401 GPVWTARFCF PGLRAQLLAA LADLGGSGLA DPHGRTGLAR LDALWAAPS
451 EPWAGAVLER LVPDTCNACP ALRQLLGGVM AAVCLQIEET AS SVKFAVCG
501 GDGGAFWGVF NVDPQDADAA SGVIEDARRA IETAVGAVLR ANAVRLRHPL
551 CLALEGVYTH AVAWSQAGVW FWNSRDNTDH LGGFPLRGPA YTTAAGWRD
601 TLRRVLGLTT ACVPEEDALT ARGLMEDACD RLILDAFNKR LDAEYWSVRV
651 SPFEASDPLP PTAFRGGALL DAEHYWRRW RVCPGGGESV GVPVDLYPRP
701 LVLPPVDCAH HLREILREIE LVFTGVLAGV WGEGGKFVYP FDDKMSFLFA
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concentrated positive charge on its surface. As UL8 bound to a phenyl sepharose column 
at only 0.1-0.3 M sodium chloride the surface of the protein must contain a high 
proportion of hydrophobic residues. It will be interesting to learn whether hydrophobic or 
negatively charged amino acids, or both, are important in the interaction of UL8 with UL5 
and UL52.
Structure of UL8 in solution.
It has been demonstrated that purified UL8 is a monomer in solution. This result is 
perhaps not surprising as UL8 exists in infected cells as a 1:1:1 complex with the UL5 and 
UL52 proteins (Crute and Lehman, 1991). An approximate value for the protein's 
molecular mass (75,000 +/- 10,000 daltons) was obtained by gel filtration. (The error is ^ 
based on a maximum error in the elution volume of +/- 0.1 ml.) Attempts to obtain a more 
accurate value for the molecular mass using glycerol gradient sedimentation were not 
successful. Purified UL8 was centrifuged through 10-30% glycerol gradients with 
standards run in parallel. This experiment was performed three times but in each case UL8 
appeared in all fractions from approximately half way down the tube — corresponding to a 
molecular mass of 150 kDal — to the bottom of the tube. The standard proteins 
centrifuged as expected from their molecular masses. Thus it appears that UL8 is not 
stable in glycerol concentrations greater than about 20% by volume. It may be possible to 
determine the precise molecular mass of UL8 using sucrose gradient centrifugation.
Nucleic acid binding properties.
The possible interaction of UL8 with duplex and single stranded DNA and 
DNA/RNA hybrids was investigated using DNA band shift assays. No binding was 
detected under a number of conditions in which known nucleic acid binding proteins did 
bind. At first sight this is a surprising result as UL8 probably stabilises nascent primers on 
DNA in vitro, when contained in the viral helicase-primase complex (Sherman et al, 
1992). One explanation is that UL8 binds nucleic acids only as part of the helicase- 
primase complex, or only in conjunction with other viral or cellular proteins. The possible 
-additional cofactors are limited to ICP8 and either the UL30/UL42 complex or E. coli 
DNA polymerase I as these were the only other proteins present in the assay of Sherman et
C
al. A specific interaction between UL8 and E. coli DNA polymerase I seem unlikely and
A
so ICP8 is probably the only possible cofactor. If binding of the UL5/UL8/UL52 complex 
to DNA can be blocked by a UL8 specific monoclonal antibody, this would be strong 
evidence that UL8 does bind to DNA as part of the full complex.
Alternatively, UL8 may be similar to other proteins whose interactions with nucleic 
acids can only be detected under certain conditions. For example, binding of the human
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DNA replication protein RF-C to DNA is revealed in a gel shift assay only after 
glutaraldehyde crosslinking and the binding is greatly enhanced by the presence of ATP 
(Tsurimoto and Stillman, 1991).
A third explanation of the failure of UL8 to bind nucleic acids is that it has 
properties analogous to proliferating cell nuclear antigen (PCNA) or the (3 subunit of E. 
coli DNA polymerase III holoenzyme. These are processivity factors for their cognate 
polymerases but do not bind DNA (see introduction). Thus UL8 may alter the DNA 
binding properties of UL5 or UL52 without contacting DNA itself.
One further structure might be investigated for interaction with UL8: a preformed 
single stranded/double stranded DNA fork which would correspond to the leading point of 
a replication fork (see diagram). Demonstrating conclusively whether purified UL8 binds 
nucleic acids will require further experiments designed to examine these possibilities.
nascent DNA
parental DNA
primer (RNA)
3'
DNA structures at a replication fork which UL8 might interact with.
Production of monoclonal antibodies and polyclonal anti-protein sera.
This thesis reports the first monoclonal antibodies specific for UL8. Nineteen cell 
lines producing monoclonal antibodies to UL8 have been developed. The variation in 
reactivity of the antibodies in the different assays (ELISA, Western blotting, and immune 
precipitations) suggests that a number of different epitopes are recognised (table 5). For 
example, reactivity in immune precipitation but not W estern blotting (e.g. MP0813) 
suggests a conformational epitope, whereas the inverse reactivity (e.g. MP0809) suggests 
recognition of an internal sequential epitope. Antibodies reactive in Western blots and 
immune precipitations suggest an external sequential epitope (e.g. M P0811) while 
antibodies reactive only in ELISA suggests a fourth type of epitope. Preliminary 
localisation of epitopes using C terminal deletions of UL8 and Western blotting (being
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carried out by E. Barnard, Institute of Virology) has produced results for two monoclonal 
antibodies. Antibody MP0817 fails to recognise a deleted protein lacking oWy the last 70 
amino acids and antibody MP0811 recognises all deletions examined so far, even one 
which retains only the first 350 amino acids of the protein. Examination of further 
antibodies is planned. The epitopes recognised can be localised more precisely using 
synthetic peptides and N terminal deletions. Two UL8 specific polyclonal sera have been 
produced by injection of the purified protein into rabbits. These sera precipitate UL8 from 
solution and recognise the protein in Western blots at a dilution of 1:4000 (figure 16). The 
availability of these antibodies will greatly facilitate future studies of UL8.
Other possible future work.
Only four possible activities have been assigned to UL8: i) a role in viral DNA 
replication — ascribed through transient assays and viral mutants (Wu et al, 1988; 
Carmichael and Weller, 1989), ii) nuclear localisation (Calder et al, 1992), iii) primer 
utilisation (Sherman et al, 1992), iv) interaction with the UL5/UL52 complex. There is no 
evidence that UL8 affects the helicase activity of the UL5/UL8/UL52 complex. Future 
work should be directed with these facts in mind.
Assaying the ability of purified UL8 to participate in HSV-1 DNA replication.
Purified UL8 must be assayed to see if it can participate in viral DNA replication. 
There are four potential assays: the coupled primase/polymerase assay of Sherman et al, 
(1992); a variation of the plasmid amplification assay of either Wu et al (1988) or Stow 
(1992); and complementation of the UL8 negative mutant hrSO (Carmichael and Weller, 
1989).
The coupled primase/polymerase assay (also called a lagging strand synthesis assay) 
consists of single stranded M13 DNA primed by the test enzyme. The activity of the 
enzyme is revealed by extending any primers with a polymerase which incorporates 
radiolabelled deoxynucleotide triphosphates. E. coli DNA polymerase I or HSV-1 
UL30/UL42 complex may be used. In this assay UL5/UL8/UL52 complex is active while 
UL5/UL52 complex is not unless UL8 is added separately. Thus purified UL8 could be 
assayed. Use of the lagging strand synthesis assay would require the proteins mentioned 
above and ICP8 and only some of these proteins are available in purified form in this 
Institute. Although complex, this system represents an important step on the road to a full 
in vitro HSV-1 DNA replication system and should be pursued. The availability of pure 
UL8 contributes to this aim.
The two plasmid amplification assays are similar. The assay of Wu et al involves 
transfecting tissue culture cells with plasmids expressing the seven replication proteins and 
a plasmid containing an HSV-1 origin. The assay of Stow involves transfecting Sf cells
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with a plasmid containing HSV-1 oris and superinfecting with seven recombinant 
baculoviruses each expressing one of the seven HSV-1 DNA replication proteins. In both 
assays the origin-containing plasmid is amplified and can be detected by its resistance to a 
methylation sensitive nuclease. Omitting the virus expressing UL8 might allow assay of 
purified UL8 by introducing the protein into the cells by electroporation, inclusion in the 
transfection mixture, liposome based transfer, or another method. The success of such an 
assay would depend on whether UL8 can be introduced into cells in a functional form, and 
whether exogenous protein can take the place of protein synthesised in the cell. With 
reference to the former, antibodies and other proteins can be introduced into cells by 
electroporation and retain function (Chen et al, 1993; Kashanchi et al, 1992).
Complementation of the UL8 negative mutant might be achieved by similar 
attempts to introduce UL8 into cells which are permissive for growth of wild type HSV-1 
but not the mutant virus. Detection of viral DNA replication or a true-late viral protein 
would indicate that UL8 was complementing the mutation.
Crystallography.
Proteins homologous to UL8 are found in varicella zoster virus (McGeoch et al, 
1988a; Davison and Scott, 1986a) and equine herpesvirus 1 (Telford et al, 1992), but not 
in human cytomegalovirus (Chee et al, 1990) or in Epstein-Barr virus (Baer et al, 1984), 
although positional homologues of the gene may exist in the last two organisms. Also, 
UL8 is the first primase subunit isolated from any organism that stabilises primers but 
apparently has no other role in the catalytic activity of the primase (Sherman et al, 1992). 
Therefore it would be very interesting to determining the three dimensional structure of the 
protein. This is practicable given the protein's size (80kDal). Crystallisation of a protein 
requires 10-100 mg of the protein as starting material (Wood, 1990), and at least the lower 
of these two figures can readily be achieved with the current purification. Growth of Sf 
cells in roller bottles or spinner cultures would make the 100 mg target realistic. The 
purification reported here yields UL8 with at least 95% purity, a suitable starting point for 
crystallography. The purified protein does not precipitate or become proteolysed for at 
least 24 hours at room temperature. In addition, a number of relevant properties of UL8 
have been deduced from the development of the purification scheme: UL8 is stable at pH  
6.1 or above (although the upper limit has not been determined); the protein is sensitive to 
ammonium sulfate, at least at 1 M and possibly below; up to 2 M sodium chloride does not 
adversely affect the protein; and 10% glycerol is required for stability but some 
concentration between 10% and 30% is too great. Given all these advantages, attempts 
should be made to crystallise UL8.
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Interaction of UL8 with other proteins.
If the ability of UL8 to participate in DNA replication cannot be measured, it may 
be possible to establish that the purified protein is in native conformation by reconstituting 
the helicase/primase by mixing UL8 and the UL5/UL52 complex. It may be that the 
UL5/UL8/UL52 complex assembles with maximum efficiency only by simultaneous de 
novo synthesis of all three proteins but this possibility can now be tested. Precipitation of 
all three proteins by a monoclonal antibody to UL8 would show that the full complex had 
been reconstituted. Alternatively, chromatographing a mixture of UL8 and UL5/UL52 
complex on a gel filtration column would show what proportion of UL8 had bound to the 
other proteins. In addition, mixing radiolabelled UL5/UL8/UL52 complex with excess 
unlabelled UL8 followed by immunoprecipitation or gel filtration would show whether 
UL8 dissociates from and reassociates with the other members of the complex at any 
appreciable rate. Naturally, if immune precipitation is employed the antibody used must 
not interfere with the interaction of the proteins. It has already been demonstrated that 
UL8 does not form a stable complex with either UL5 or UL52 alone (Dodson and Lehman, 
1991).
If UL8 stabilises primers, the protein may interact with the viral polymerase as the 
primer terminus must be transferred to the polymerase, perhaps into a groove on its 
surface. The DNA duplex containing the nascent strand is contained in such a groove on 
the surface of E. coli DNA polymerase I (Freemont et al, 1988). Primer-template 
duplexes may interact similarly with the surface of UL8 allowing the primer's 3' terminus 
to be transferred into the polymerase active site. A physical association between UL8 and 
the polymerase during this process is possible rather than probable however as both E. 
coli DNA polymerase I and HSV-1 DNA polymerase can extend primers stabilised by 
UL8 (Sherman et al, 1992), and a site of interaction with UL8 is unlikely to have been 
conserved between the two polymerases. No interaction of UL8 and ICP8 has been 
demonstrated but such an interaction is also possible as ICP8 may coat all single stranded 
DNA at a replication fork.
The availability of monoclonal antibodies to UL8 will allow regions of the protein 
involved in particular functions to be identified. Interaction of UL8 with four groups of 
macromolecules may be examined: nucleic acids; UL5/UL52 complex; viral UL30/UL42 
complex; and ICP8, the HSV-1 single stranded DNA binding protein. If UL8 binds 
primer-template complexes when part of the helicase-primase, this interaction might be 
blocked by appropriate monoclonal antibodies, identifying the region or regions involved. 
If UL8 binds strongly to UL5/UL52 then disrupting the preformed complex may not be 
possible. However, preventing the two portions of the complex associating using an 
antibody may still be possible. Some monoclonal antibodies bind only free UL8 and not 
UL8 contained in the UL5/UL8/UL52 complex, supporting this proposal (G. McLean,
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Institute of Virology, personal communication).
It may be possible, with appropriate peptides, to disrupt protein-protein interactions 
identified using monoclonal antibodies. If the interaction is essential the disruption has the 
potential to prevent viral DNA replication. Disruption by peptides has been achieved for 
other protein-protein interactions (reviewed by Marsden, 1992) and such peptides are 
potential lead compounds for the development of antiviral drugs.
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